Exhibit 1.1
11,500,000 UNITS
REGENERX BIOPHARMACEUTICALS, INC.
UNDERWRITING AGREEMENT
May
17, 2010
MAXIM GROUP LLC
405 Lexington Avenue
New York, NY 10174
As Representative of the Underwriters
named on
Schedule A
hereto
Ladies and Gentlemen:
RegeneRx Biopharmaceuticals, Inc., a corporation organized and existing under the laws of the
State of Delaware (the
Company
), confirms its agreement, subject to the terms and conditions set
forth herein, with each of the underwriters listed on
Exhibit A
hereto (collectively, the
Underwriters
), for whom Maxim Group LLC is acting as representative (in such capacity, the
Representative
), to sell and issue to the
Underwriters an aggregate of 11,500,000 units, each unit
consisting of one (1) share of common stock, par value of $0.001
(the
Common Shares
), or 11,500,000
shares in the aggregate, and 0.4 of a tradeable warrant to purchase
one Common Share, or 4,600,000
warrants in the aggregate, (the
Warrants
) of the Company (each, a
Firm Unit
). The Warrants are
being issued pursuant to and shall have the rights and privileges set forth in that certain Warrant
Agreement, dated as of the date hereof, between the Company and American Stock Transfer & Trust
Company (the
Warrant Agreement
). The Firm Units are more fully described in the Registration
Statement and Prospectus referred to below.
The offering and sale of the Units (as defined herein) contemplated by this underwriting
agreement (this
Agreement
) is referred to herein as the
Offering
.
1.
Firm Units; Over-Allotment Option
.
(a)
Purchase of Firm Units
. On the basis of the representations and
warranties herein contained, but subject to the terms and conditions herein set forth, the Company
agrees to issue and sell, severally and not jointly, to the several Underwriters, an aggregate of
11,500,000 Firm Units of the Company at a purchase price (net of
discounts and commissions) of $0.3772 per
Firm Unit (exclusive of any Units sold to Sigma Tau (as defined herein) which shall be sold to the
several Underwriters at a purchase price of
$0.41 per Firm Unit. The Underwriters, severally and
not jointly, agree to purchase from the Company the number of Firm Units set forth opposite their
respective names on
Schedule A
attached hereto and made a part hereof at a purchase price (net of
discounts and commissions) of $0.3772 per Firm
Maxim Group LLC
May 17, 2010
Page 2 of 44
Unit
(exclusive of any Units sold to Sigma Tau (as defined herein) which
shall be sold to the several Underwriters at a purchase price of
$0.41 per firm Unit). In addition, the Company shall pay the Representative a corporate finance fee equal to
one percent (1%), or $0.0041 per Firm Unit. The corporate financing fee shall be paid to the
Representative for structuring the terms of the Offering. The Common Shares contained in the Units
and the Warrants will separate immediately following issuance of the Units. There will be no
market for the Units.
(b)
Payment and Delivery
. Delivery and payment for the Firm Units shall be
made at 10:00 A.M., New York time, on the third Business Day following the effective date (the
Effective Date
) of the Registration Statement (or the fourth Business Day following the Effective
Date, if the Registration Statement is declared effective after 4:30 p.m.) or at such earlier time
as shall be agreed upon by the Representative and the Company at the offices of the Representative
or at such other place as shall be agreed upon by the Representative and the Company. The hour and
date of delivery and payment for the Firm Units is called the
Closing Date
. The closing of the
payment of the purchase price for, and delivery of certificates representing, the Firm Units is
referred to herein as the
Closing
. Payment for the Firm Units shall be made on the Closing Date
at the Representatives election by wire transfer in Federal (same day) funds or by certified or
bank cashiers check(s) in New York Clearing House funds. Any remaining proceeds (less
commissions, expense allowance and actual expense payments or other fees payable pursuant to this
Agreement) shall be paid to the order of the Company upon delivery to you of certificates (in form
and substance satisfactory to the Underwriters) representing the Common Shares and Warrant
underlying the Firm Units (or through the full fast transfer facilities of the Depository Trust
Company (the
DTC
)) for the account of the Underwriters. The Firm Units shall be registered in
such name or names and in such authorized denominations as the Representative may request in
writing at least two Business Days prior to the Closing Date. The Company will permit the
Representative to examine and package the Firm Units for delivery, at least one full Business Day
prior to the Closing Date. The Company shall not be obligated to sell or deliver the Firm Units
except upon tender of payment by the Representative for all the Firm Units.
(c)
Option Units
. For the purposes of covering any over-allotments in
connection with the distribution and sale of the Firm Units, the Representative on behalf of the
Underwriters is, hereby granted, an option to purchase up to an additional fifteen percent (15%) of
the total number of Firm Units (the
Option Units
) to be offered by the Company in the Offering
(the
Over-allotment Option
). The Firm Units and the Option Units are hereinafter collectively
referred to as the
Units
. The Units, the Common Shares, the Warrants, the Warrant Shares, and
the Representatives Securities (as hereinafter defined) are referred to as (the
Securities
).
The purchase price to be paid for the Option Units (net of discounts
and commissions) will be $0.3772
per Option Unit. In addition, the Company shall pay the Representative a corporate finance fee
equal to one percent (1%), or $0.0041 per Firm Unit. The corporate financing fee shall be paid to
the Representative for structuring the terms of the Offering.
(d)
Exercise of Option
. The Over-allotment Option granted pursuant to
Section 1.1(c) hereof may be exercised by the Representative as to all (at any time) or any part
-2-
Maxim Group LLC
May 17, 2010
Page 3 of 44
(from time to time) of the Option Units within forty-five (45) days after the Effective Date.
The Underwriters will not be under any obligation to purchase any Option Units prior to the
exercise of the Over-allotment Option. The Over-allotment Option granted hereby may be exercised
by the giving of oral notice to the Company from the Representative, which must be confirmed in
writing by overnight mail, electronic mail, or facsimile transmission setting forth the number of
Option Units to be purchased and the date and time for delivery of and payment for the Option
Units, which will not be later than five (5) Business Days after the date of the notice or such
other time as shall be agreed upon by the Company and the Representative, at the offices of the
Representative or at such other place as shall be agreed upon by the Company and the
Representative. If such delivery and payment for the Option Units does not occur on the Closing
Date, the date and time of the closing for such Option Units will be as set forth in the notice
(hereinafter the
Option Closing Date
). Upon exercise of the Over-allotment Option, the Company
will become obligated to convey to the Underwriters, and, subject to the terms and conditions set
forth herein, the Underwriters will become obligated to purchase, the number of Option Units
specified in such notice.
(e)
Payment and Delivery of Option Units
. Payment for the Option Units
shall be made on the Option Closing Date at the Representatives election by wire transfer in
Federal (same day) funds or by certified or bank cashiers check(s) in New York Clearing House
funds, by deposit of the sum of $0.3772 per Option Unit to the Company upon delivery to the
Underwriters of certificates (in form and substance satisfactory to the Underwriters) representing
the Common Shares and Warrants underlying the Option Units (or through the full fast transfer
facilities of DTC) for the account of the Underwriters. The certificates representing the Common
Shares and Warrants underlying the Option Units to be delivered will be in such denominations and
registered in such names as the Representative requests not less than two Business Days prior to
the Closing Date or the Option Closing Date, as the case may be, and will be made available to the
Representative for inspection, checking and packaging at the aforesaid office of the Companys
transfer agent or correspondent not less than one full Business Day prior to such Closing Date or
Option Closing Date.
(f)
Representatives Warrants
. As additional consideration, the Company
hereby agrees to issue and sell to the Representative (or their respective designees) on the
Effective Date, a warrant (the
Representatives
Warrant
) for the purchase of an aggregate of
805,000
shares of Common Stock (which is seven percent (7%) of the Common Shares underlying the Firm Units
sold in the Offering). The Representatives Warrant shall be exercisable, in whole or in part,
commencing on the date that is six months from the Effective Date and expiring on the five-year
anniversary of the Effective Date at an initial exercise price per
unit of $0.45, which is equal to
one hundred and ten percent (110%) of the public offering price of a Unit. The Representatives
Warrant and the Common Shares issuable upon exercise of the Representatives Warrant are
hereinafter referred to collectively as the
Representatives Securities
.
-3-
Maxim Group LLC
May 17, 2010
Page 4 of 44
2.
Representations and Warranties of the Company
.
2.1 The Company represents, warrants and covenants to, and agrees with, each of the
Underwriters that, as of the date hereof and as of the Closing Date:
(a) The Company has prepared and filed with the Securities and Exchange Commission (the
Commission
) a registration statement on Form S-1 (Registration No. 333-166146), and amendments
thereto, and related preliminary prospectuses for the registration under the Securities Act of
1933, as amended (the
Securities Act
), of the Securities which registration statement, as so
amended (including post-effective amendments, if any), has been declared effective by the
Commission and copies of which have heretofore been delivered to the Underwriters. The
registration statement, as amended at the time it became effective, including the prospectus,
financial statements, schedules, exhibits and other information (if any) deemed to be part of the
registration statement at the time of effectiveness pursuant to Rule 430A under the Securities Act,
is hereinafter referred to as the
Registration Statement
. If the Company has filed or is
required pursuant to the terms hereof to file a registration statement pursuant to Rule 462(b)
under the Securities Act registering additional Units (a
Rule 462(b) Registration Statement
),
then, unless otherwise specified, any reference herein to the term Registration Statement shall
be deemed to include such Rule 462(b) Registration Statement. Other than a Rule 462(b)
Registration Statement, which, if filed, becomes effective upon filing, no other document with
respect to the Registration Statement has heretofore been filed with the Commission. All of the
Securities have been registered under the Securities Act pursuant to the Registration Statement or,
if any Rule 462(b) Registration Statement is filed, will be duly registered under the Securities
Act with the filing of such Rule 462(b) Registration Statement. The Company has responded to all
requests of the Commission for additional or supplemental information. Based on communications
from the Commission, no stop order suspending the effectiveness or use of either the Registration
Statement or the Rule 462(b) Registration Statement, if any, has been issued and no proceeding for
that purpose has been initiated or threatened by the Commission. The Company, if required by the
Securities Act and the rules and regulations of the Commission (the
Rules and Regulations
),
proposes to file the Prospectus with the Commission pursuant to Rule 424(b) under the Securities
Act (
Rule 424(b)
). The prospectus, in the form in which it is to be filed with the Commission
pursuant to Rule 424(b), or, if the prospectus is not to be filed with the Commission pursuant to
Rule 424(b), the prospectus in the form included as part of the Registration Statement at the time
the Registration Statement became effective, is hereinafter referred to as the
Prospectus
, except
that if any revised prospectus or prospectus supplement shall be provided to the Underwriters by
the Company for use in connection with the Offering which differs from the Prospectus (whether or
not such revised prospectus or prospectus supplement is required to be filed by the Company
pursuant to Rule 424(b)), the term Prospectus shall also refer to such revised prospectus or
prospectus supplement, as the case may be, from and after the time it is first provided to the
Underwriters for such use. Any preliminary prospectus or prospectus dated on or after April 27,
2010 subject to completion included in the Registration Statement or filed with the Commission
pursuant to Rule 424 under the Securities Act is hereafter called a
Preliminary Prospectus
.
-4-
Maxim Group LLC
May 17, 2010
Page 5 of 44
Any reference herein to the Registration Statement, any Preliminary Prospectus or the
Prospectus shall be deemed to refer to and include the exhibits incorporated by reference therein
pursuant to the Rules and Regulations on or before the effective date of the Registration
Statement, the date of such Preliminary Prospectus or the date of the Prospectus, as the case may
be. Any reference herein to the terms amend, amendment or supplement with respect to the
Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to
and include: (i) the filing of any document under the Securities Exchange Act of 1934, as amended,
and together with the Rules and Regulations promulgated thereunder (the
Exchange Act
) after the
effective date of the Registration Statement, the date of such Preliminary Prospectus or the date
of the Prospectus, as the case may be, which is incorporated therein by reference, and (ii) any
such document so filed. All references in this Agreement to the Registration Statement, the Rule
462(b) Registration Statement, a Preliminary Prospectus and the Prospectus, or any amendments or
supplements to any of the foregoing shall be deemed to include any copy thereof filed with the
Commission pursuant to its Electronic Data Gathering Analysis and Retrieval System (
EDGAR
).
(b) At the time of the effectiveness of the Registration Statement or any Rule 462(b)
Registration Statement or the effectiveness of any post-effective amendment to the Registration
Statement, when the Prospectus is first filed with the Commission pursuant to Rule 424(b), when any
supplement to or amendment of the Prospectus is filed with the Commission, when any document filed
under the Exchange Act was or is filed, at all other subsequent times until the completion of the
public offer and sale of the Securities, and at the Closing Date (as hereinafter defined), if any,
the Registration Statement and the Prospectus and any amendments thereof and supplements or
exhibits thereto complied or will comply in all material respects with the applicable provisions of
the Securities Act and the Rules and Regulations, and did not and will not contain an untrue
statement of a material fact and did not and will not omit to state any material fact required to
be stated therein or necessary to make the statements therein: (i) in the case of the Registration
Statement, not misleading, and (ii) in the case of the Prospectus in light of the circumstances
under which they were made, not misleading. When any Preliminary Prospectus was first filed with
the Commission (whether filed as part of the Registration Statement for the registration of the
Securities or any amendment thereto or pursuant to Rule 424(a) under the Securities Act) and when
any amendment thereof or supplement thereto was first filed with the Commission at the Time of Sale
(as defined below) and at the Closing Date, such Preliminary Prospectus and any amendments thereof
and supplements thereto complied in all material respects with the applicable provisions of the
Securities Act and the Rules and Regulations and did not contain an untrue statement of a material
fact and did not omit to state any material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading.
No representation and warranty is made in this subsection (b), however, with respect to any
information contained in or omitted from the Registration Statement or the Prospectus or any
related Preliminary Prospectus or any amendment thereof or supplement thereto in reliance upon and
in conformity with information furnished in writing to the Company by or on behalf of any
Underwriter through the Representative specifically for use therein. The parties acknowledge and
agree that such information provided by or on behalf of any Underwriter consists solely of the
fourth paragraph
-5-
Maxim Group LLC
May 17, 2010
Page 6 of 44
of the Underwriting section of the Prospectus, the last two paragraphs of the subsection
captioned Other Terms and the subsection captioned Stabilization of the Underwriting section
of the Prospectus (the
Underwriters Information
).
(c) Neither: (i) any Issuer-Represented General Free Writing Prospectus(es) (as defined below)
issued at or prior to the Time of Sale and the Statutory Prospectus (as defined below) at the Time
of Sale, all considered together (collectively, the
General Disclosure Package
), nor (ii) any
individual Issuer-Represented Limited-Use Free Writing Prospectus(es) (as defined below), when
considered together with the General Disclosure Package, includes or included as of the Time of
Sale and the Closing Date (as the case may be), any untrue statement of a material fact or omits or
omitted as of the Time of Sale and the Closing Date (as the case may be) to state any material fact
necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading. The preceding sentence does not apply to statements in or omissions from any
Statutory Prospectus included in the Registration Statement or any Issuer-Represented Free Writing
Prospectus (as defined below) based upon and in conformity with written information furnished to
the Company by the Representative specifically for use therein.
(d) Each Issuer-Represented Free Writing Prospectus, as of its issue date and at all
subsequent times through the completion of the public offer and sale of the Securities or until any
earlier date that the Company notified or notifies the Representative as described in the next
sentence, did not, does not and will not include any information that conflicted, conflicts or will
conflict with the information contained in the Registration Statement, the General Disclosure
Package or the Prospectus. If at any time following issuance of an Issuer-Represented Free Writing
Prospectus there occurred or occurs an event or development as a result of which such
Issuer-Represented Free Writing Prospectus conflicted or would conflict with the information
contained in the Registration Statement, the General Disclosure Package or the Prospectus relating
to the Securities or included or would include an untrue statement of a material fact or omitted or
would omit to state a material fact necessary to make the statements therein, in the light of the
circumstances prevailing at that subsequent time, not misleading, the Company has notified or will
notify promptly the Representative so that any use of such Issuer-Represented Free Writing
Prospectus may cease until it is promptly amended or supplemented by the Company, at its own
expense, to eliminate or correct such conflict, untrue statement or omission. The foregoing two
sentences do not apply to statements in or omissions from any Issuer-Represented Free Writing
Prospectus based upon and in conformity with written information furnished to the Company by the
Representative specifically for use therein.
(e) The Company has not distributed and will not distribute any prospectus or other offering
material in connection with the offering and sale of the Securities other than the General
Disclosure Package or the Prospectus or other materials permitted by the Act to be distributed by
the Company. Unless the Company obtains the prior consent of the Representative, the Company has
not made and will not make any offer relating to the Securities that would constitute an issuer
free writing prospectus, as defined in Rule 433 under the Act, or that would otherwise constitute
a free writing prospectus, as defined in Rule 405 under the
-6-
Maxim Group LLC
May 17, 2010
Page 7 of 44
Act, required to be filed with the Commission. The Company has complied and will comply with
the requirements of Rules 164 and 433 under the Act applicable to any Issuer-Represented Free
Writing Prospectus as of its issue date and at all subsequent times through the completion of the
public offer and sale of the Securities, including timely filing with the Commission where
required, legending and record keeping. The Company has satisfied and will satisfy the conditions
in Rule 433 under the Act to avoid a requirement to file with the Commission any electronic road
show. Neither the Company nor any Underwriter are disqualified, by reason of subsection (f) or (g)
of Rule 164 under the Act, from using, in connection with the offer and sale of the Units, free
writing prospectuses (as defined in Rule 405 under the Act) pursuant to Rules 164 and 433 under
the Act; the Company is not an ineligible issuer (as defined in Rule 405 under the Act) as of the
eligibility determination date for purposes of Rule 164 and 433 under the Act with respect to the
offering of the Firm Units contemplated by the Registration Statement, the General Disclosure
Package, and the Prospectus.
(f) Each Underwriter agrees that, unless it obtains the prior written consent of the Company,
it will not make any offer relating to the Securities that would constitute an Issuer-Represented
Free Writing Prospectus (as defined below) or that would otherwise (without taking into account any
approval, authorization, use or reference thereto by the Company) constitute a free writing
prospectus required to be filed by the Company with the Commission or retained by the Company
under Rule 433 of the Securities Act; provided that the prior written consent of the Company hereto
shall be deemed to have been given in respect of any Issuer-Represented General Free Writing
Prospectuses referenced on
Schedule C
attached hereto
(g) As used in this Agreement, the terms set forth below shall have the following meanings:
(i)
Time
of Sale
means 4:30 p.m.
(Eastern time) on the date of this Agreement.
(ii)
Statutory Prospectus
as of any time means the prospectus that is included in the
Registration Statement immediately prior to that time. For purposes of this definition,
information contained in a form of prospectus that is deemed retroactively to be a part of the
Registration Statement pursuant to Rule 430A or 430B shall be considered to be included in the
Statutory Prospectus as of the actual time that form of prospectus is filed with the Commission
pursuant to Rule 424(b) under the Act.
-7-
Maxim Group LLC
May 17, 2010
Page 8 of 44
(iii)
Issuer-Represented Free Writing Prospectus
means any issuer free writing prospectus,
as defined in Rule 433 under the Act, relating to the Securities that (A) is required to be filed
with the Commission by the Company, or (B) is exempt from filing pursuant to Rule 433(d)(5)(i)
under the Act because it contains a description of the Securities or of the offering that does not
reflect the final terms or pursuant to Rule 433(d)(8)(ii) because it is a bona fide electronic
road show, as defined in Rule 433 of the Regulations, in each case in the form filed or required
to be filed with the Commission or, if not required to be filed, in the form retained in the
Companys records pursuant to Rule 433(g) under the Act.
(iv)
Issuer-Represented General Free Writing Prospectus
means any Issuer-Represented Free
Writing Prospectus that is intended for general distribution to prospective investors, as evidenced
by its being specified in
Schedule C
to this Agreement.
(v)
Issuer-Represented Limited-Use Free Writing Prospectus
means any Issuer-Represented Free
Writing Prospectus that is not an Issuer-Represented General Free Writing Prospectus. The term
Issuer-Represented Limited-Use Free Writing Prospectus also includes any bona fide electronic road
show, as defined in Rule 433 of the Regulations, that is made available without restriction
pursuant to Rule 433(d)(8)(ii), even though not required to be filed with the Commission.
(h) To the knowledge of the Company, Reznick Group P.C.
(
Reznick
)
, whose reports relating to
the Company are included in the Registration Statement, are independent public accountants as
required by the Securities Act, the Exchange Act and the Rules and Regulations and such accountants
are not in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002
(
Sarb-Ox
).
(i) Subsequent to the respective dates as of which information is presented in the
Registration Statement, the General Disclosure Package and the Prospectus, and except as disclosed
in the Registration Statement, the General Disclosure Package and the Prospectus: (i) the Company
has not declared, paid or made any dividends or other distributions of any kind on or in respect of
its capital stock, and (ii) there has been no material adverse change (or, to the knowledge of the
Company, any development which has a high probability of involving a material adverse change in the
future), whether or not arising from transactions in the ordinary course of business, in or
affecting: (A) the business, condition (financial or otherwise), results of operations,
shareholders equity, properties or prospects of the Company, taken as a whole; (B) the long-term
debt or capital stock of the Company; or (C) the Offering or consummation of any of the other
transactions contemplated by this Agreement, the Registration Statement, the General Disclosure
Package and the Prospectus (a
Material Adverse Change
). Since the date of the latest balance
sheet presented in the Registration Statement, the General Disclosure Package and the Prospectus,
the Company has not incurred or undertaken any liabilities or obligations, whether direct or
indirect, liquidated or contingent, matured or unmatured, or entered into any transactions,
including any acquisition or disposition of any business or asset, which are material to the
Company taken as a whole, except for liabilities, obligations and transactions which are disclosed
in the Registration Statement and the Prospectus.
-8-
Maxim Group LLC
May 17, 2010
Page 9 of 44
(j) As of the dates indicated in the Registration Statement, the General Disclosure Package
and the Prospectus, the authorized, issued and outstanding shares of capital stock of the Company
were as set forth in the Registration Statement, the General Disclosure Package and the Prospectus
in the column headed Actual under the section thereof captioned Capitalization and, after
giving effect to the Offering and the other transactions contemplated by this Agreement, the
Registration Statement, the General Disclosure Package and the Prospectus, will be as set forth in
the column headed As Adjusted in such section. Notwithstanding the foregoing, the authorized
shares of capital stock are subject to increase between the date of this Agreement and the Option
Closing Date as reflected in the Registration Statement, the General Disclosure Package and the
Prospectus. All of the issued and outstanding shares of capital stock of the Company, including the
outstanding Common Shares of the Company, are fully paid and non-assessable and have been duly and
validly authorized and issued, in compliance with all applicable state, federal and foreign
securities laws and not in violation of or subject to any preemptive or similar right that does or
will entitle any Person (as defined below), upon the issuance or sale of any security, to acquire
from the Company any Relevant Security. As used herein, the term
Relevant Security
means any
Common Shares or other security of the Company that is convertible into, or exercisable or
exchangeable for Common Shares or equity securities, or that holds the right to acquire any Common
Shares or equity securities of the Company or any other such Relevant Security, except for such
rights as may have been fully satisfied or waived prior to the effectiveness of the Registration
Statement. As used herein, the term
Person
means any foreign or domestic individual,
corporation, trust, partnership, joint venture, limited liability company or other entity. Except
as set forth in, or contemplated by, the Registration Statement, the General Disclosure Package and
the Prospectus, on the Effective Date and on the Closing Date, there will be no options, warrants,
or other rights to purchase or otherwise acquire any authorized, but unissued Common Shares or any
security convertible into Common Shares, or any contracts or commitments to issue or sell Common
Shares or any such options, warrants, rights or convertible securities.
(k) The Common Shares underlying the Units have been duly and validly authorized and, when
issued, delivered and paid for in accordance with this Agreement on the Closing Date, will be duly
and validly issued, fully paid and non-assessable, will have been issued in compliance with all
applicable state, federal and foreign securities laws and will not have been issued in violation of
or subject to any preemptive or similar right that does or will entitle any Person to acquire any
Relevant Security from the Company upon issuance or sale of the Units in the Offering. The Units
and the Common Shares and Warrants underlying the Units conform to the descriptions thereof
contained in the Registration Statement, the General Disclosure Package and the Prospectus.
(l) The Common Shares underlying the Warrants and the Representatives Warrants have been duly
authorized for issuance, will conform to the description thereof in the Registration Statement and
in the Prospectus and have been validly reserved for future issuance and will, upon exercise of the
Representatives Warrants and payment of the exercise price thereof, be duly and validly issued,
fully paid and non-assessable and will not have been issued
-9-
Maxim Group LLC
May 17, 2010
Page 10 of 44
in violation of or subject to preemptive or similar rights to subscribe for or purchase
securities of the Company. The issuance of such securities is not subject to any statutory
preemptive rights under the laws of the State of Delaware or the Companys organization documents
as in effect at the time of issuance, rights of first refusal or other similar rights of any
securityholder of the Company (except for such preemptive or contractual rights as were waived).
(m) The Company has no subsidiaries within the meaning of Rule 405 under the Securities Act.
The Company holds no ownership or other interest, nominal or beneficial, direct or indirect, in any
corporation, partnership, joint venture or other business entity. No director, officer or key
employee of the Company named in the Prospectus holds any direct equity, debt or other pecuniary
interest in any Person with whom the Company does business or is in privity of contract with, other
than, in each case, indirectly through the ownership by such individuals of Common Shares.
(n) The Company has been duly incorporated, formed or organized, and validly exists as a
corporation, partnership or limited liability company in good standing under the laws of its
jurisdiction of incorporation, formation or organization. The Company has all requisite power and
authority to carry on its business as it is currently being conducted and as described in the
Registration Statement, the General Disclosure Package and the Prospectus, and to own, lease and
operate its respective properties. The Company is duly qualified to do business and is in good
standing as a foreign corporation, partnership or limited liability company in each jurisdiction in
which the character or location of its properties (owned, leased or licensed) or the nature or
conduct of its business makes such qualification necessary, except, in each case, for those
failures to be so qualified or in good standing which (individually and in the aggregate) could not
reasonably be expected to have a material adverse effect on: (i) the business, condition (financial
or otherwise), results of operations, shareholders equity, properties or prospects of the Company,
taken as a whole; (ii) the long-term debt or capital stock of the Company; or (iii) the Offering or
consummation of any of the other transactions contemplated by this Agreement, the Registration
Statement, the General Disclosure Package and the Prospectus (any such effect being a
Material
Adverse Effect
).
(o) The Company is not: (i) in violation of its certificate or articles of incorporation,
by-laws, certificate of formation, limited liability company agreement, joint venture agreement,
partnership agreement or other organizational documents, (ii) in default under, and no event has
occurred which, with notice or lapse of time or both, would constitute a default under or result in
the creation or imposition of any lien, charge, mortgage, pledge, security interest, claim, equity,
trust or other encumbrance, preferential arrangement, defect or restriction of any kind whatsoever
(any
Lien
) upon any of its property or assets pursuant to, any indenture, mortgage, deed of
trust, loan agreement or other agreement or instrument to which it is a party or by which it is
bound or to which any of its property or assets is subject or (iii) in violation in any respect of
any law, rule, regulation, ordinance, directive, judgment, decree or order of any judicial,
regulatory or other legal or governmental agency or body, foreign or domestic, except (in the case
of clause (ii) above) for any Lien, charge or encumbrance disclosed in the Registration Statement,
the General Disclosure Package and the Prospectus or
-10-
Maxim Group LLC
May 17, 2010
Page 11 of 44
for such violations or defaults that would not, individually or in the aggregate, be expected
to result in a Material Adverse Effect.
(p) The Company has full right, power and authority to execute and deliver this Agreement, the
Warrant Agreement the Representatives Warrants, and all other agreements, documents, certificates
and instruments required to be delivered pursuant to this Agreement. The Company has duly and
validly authorized this Agreement, the Representatives Warrants and each of the transactions
contemplated by this Agreement and the Representatives Warrants. This Agreement and the
Representatives Warrants have been duly and validly executed and delivered by the Company and
constitute the legal, valid and binding obligations of the Company and are enforceable against the
Company in accordance with their terms, except as enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors rights
generally and except as enforceability may be subject to general principles of equity (regardless
of whether such enforceability is considered in a proceeding in equity or at law).
(q) The execution, delivery, and performance of this Agreement, the Representatives Warrants
and all other agreements, documents, certificates and instruments required to be delivered pursuant
to this Agreement, and consummation of the transactions contemplated by this Agreement do not and
will not: (i) conflict with, require consent under or result in a breach of any of the terms and
provisions of, or constitute a default (or an event which with notice or lapse of time, or both,
would constitute a default) under, or result in the creation or imposition of any Lien upon any
property or assets of the Company pursuant to, any indenture, mortgage, deed of trust, loan
agreement or other agreement, instrument, franchise, license or permit to which the Company is a
party or by which the Company or its properties, operations or assets may be bound or (ii) violate
or conflict with any provision of the certificate or articles of incorporation, by-laws,
certificate of formation, limited liability company agreement, partnership agreement or other
organizational documents of the Company, or (iii) violate or conflict with any law, rule,
regulation, ordinance, directive, judgment, decree or order of any judicial, regulatory or other
legal or governmental agency or body, domestic or foreign.
(r) The Company has all consents, approvals, authorizations, orders, registrations,
qualifications, licenses, filings and permits of, with and from all judicial, regulatory and other
legal or governmental agencies and bodies and all third parties, foreign and domestic
(collectively, the
Consents
), to own, lease and operate its properties and conduct its business
as it is now being conducted and as disclosed in the Registration Statement, the General Disclosure
Package and the Prospectus, and each such Consent is valid and in full force and effect, except for
such consents, approvals, authorizations, orders, registrations, qualifications, licenses, filings
and permits, the failure to have would not, individually or in the aggregate, be expected to result
in a Material Adverse Effect. The Company has not received notice of any investigation or
proceedings which results in or, if decided adversely to the Company, could reasonably be expected
to result in, the revocation of, or imposition of a materially burdensome restriction on, any
Consent. No Consent contains a materially burdensome restriction not adequately disclosed in the
Registration Statement, the General Disclosure Package and the Prospectus.
-11-
Maxim Group LLC
May 17, 2010
Page 12 of 44
(s) The Company is in compliance with all applicable laws, rules, regulations, ordinances,
directives, judgments, decrees and orders, foreign and domestic, except for such non-compliance as
would not, individually or in the aggregate, be expected to result in a Material Adverse Effect.
Neither the Company, nor, to the Companys knowledge, any of its Affiliates (within the meaning of
Rule 144 under the Securities Act) (
Affiliates
) has received any notice or other information from
any regulatory or other legal or governmental agency relating to any default or potential
decertification by the Company, or any of its Affiliates.
(t) No Consent of, with or from any judicial, regulatory or other legal or governmental agency
or body or any third party, foreign or domestic is required for the execution, delivery and
performance of this Agreement, the Representatives Warrants or consummation of each of the
transactions contemplated by this Agreement, including the issuance, sale and delivery of the
Securities to be issued, sold and delivered hereunder, except the registration under the Securities
Act of the Securities, which has become effective, and such Consents as may be required under state
securities or blue sky laws or the by-laws and rules of the NYSE Amex stock exchange, where the
Common Shares have been approved for listing, and the Financial Industry Regulatory Authority, Inc.
(
FINRA
) in connection with the purchase and distribution of the Securities by the Underwriters,
each of which has been obtained and is in full force and effect.
(u) Except as disclosed in the Registration Statement, the General Disclosure Package and the
Prospectus, there is no judicial, regulatory, arbitral or other legal or governmental proceeding or
other litigation or arbitration, domestic or foreign, pending to which the Company is a party or of
which any property, operations or assets of the Company is the subject which, individually or in
the aggregate, if determined adversely to the Company, could reasonably be expected to have a
Material Adverse Effect. To the Companys knowledge, no such proceeding, litigation or arbitration
is threatened or contemplated; and the defense of all such proceedings, litigation and arbitration
against or involving the Company could not reasonably be expected to have a Material Adverse
Effect.
(v) The financial statements, including the notes thereto, and the supporting schedules
included in the Registration Statement, the General Disclosure Package and the Prospectus comply in
all material respects with the requirements of the Securities Act and present fairly the financial
position as of the dates indicated and the cash flows and results of operations for the periods
specified of the Company. Except as otherwise stated in the Registration Statement, the General
Disclosure Package and the Prospectus, said financial statements have been prepared in conformity
with United States generally accepted accounting principles applied on a consistent basis
throughout the periods involved, except in the case of unaudited financials which are subject to
normal year end adjustments and do not contain certain footnotes. No other financial statements or
supporting schedules are required to be included or incorporated by reference in the Registration
Statement, the General Disclosure Package or the Prospectus. The other financial and statistical
information included in the Registration Statement, the General Disclosure Package and the
Prospectus present fairly the information
-12-
Maxim Group LLC
May 17, 2010
Page 13 of 44
included therein and have been prepared on a basis consistent with that of the financial
statements that are included in the Registration Statement, the General Disclosure Package and the
Prospectus and the books and records of the Company.
(w) There are no pro forma or as adjusted financial statements which are required to be
included in the Registration Statement, the General Disclosure Package and the Prospectus in
accordance with Regulation S-X which have not been included as so required. The as adjusted
financial information included in the Registration Statement, the General Disclosure Package and
the Prospectus has been properly compiled and prepared in accordance with the applicable
requirements of the Securities Act and the Rules and Regulations and include all adjustments
necessary to present fairly in accordance with generally accepted accounting principles the as
adjusted financial position of the Company at the date indicated. The assumptions used in
preparing the as adjusted financial information included in the Registration Statement, the General
Disclosure Package and the Prospectus provide a reasonable basis for presenting the significant
effects directly attributable to the transactions or events described therein. The related
adjustments give appropriate effect to those assumptions and the as adjusted financial information
reflect the proper application of those adjustments to the corresponding historical financial
statement amounts.
(x) The statistical, industry-related and market-related data included in the Registration
Statement, the General Disclosure Package and the Prospectus are based on or derived from sources
which the Company reasonably and in good faith believes are reliable and accurate, and such data
agree with the sources from which they are derived.
(y) The Company is subject to the reporting requirements of Section 13 or 15(d) of the
Exchange Act and files reports with the Commission on EDGAR. The Common Shares and Warrants are
registered pursuant to Section 12(b) or 12(g) of the Exchange Act and the outstanding Common Shares are listed on the NYSE Amex stock exchange. The Company has taken no action designed to,
or likely to have the effect of, terminating the registration of the Common Shares under the
Exchange Act or de-listing the Common Shares from the NYSE Amex stock exchange,
except as set forth in the Registration Statement, the General Disclosure Package and the
Prospectus nor has the Company received any notification that the Commission or NYSE Amex stock
exchange is contemplating terminating such registration or listing. Since January 1, 2009, the
Company has timely filed all reports, schedules, forms, statements and other documents required to
be filed by it with the Commission pursuant to the reporting requirements of the Exchange Act (all
of the foregoing, and all other documents and registration statements heretofore filed by the
Company with the Commission being hereinafter referred to as the
SEC Documents
). None of the SEC
Documents, at the time they were filed with the Commission (except those SEC Documents that were
subsequently amended), contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary to make the statements therein, in light
of the circumstances under which they were made, not misleading. As of their respective dates, the
financial statements of the Company included (or incorporated by reference) in the SEC Documents
complied as to form in all material respects with applicable accounting
-13-
Maxim Group LLC
May 17, 2010
Page 14 of 44
requirements and the published rules and regulations of the Commission or other applicable
rules and regulations with respect thereto (except those SEC Documents that were subsequently
amended).
(z) The Company has established and maintains disclosure controls and procedures (as defined
in Rules 13a-14 and 15d-14 under the Exchange Act) and such controls and procedures are effective
in ensuring that material information relating to the Company, is made known to the principal
executive officer and the principal financial officer. The Company has utilized such controls and
procedures in preparing and evaluating the disclosures in the Registration Statement, in the
General Disclosure Package and in the Prospectus.
(aa) The Company maintains a system of internal accounting controls sufficient to provide
reasonable assurances that (A) transactions are executed in accordance with managements general or
specific authorization; (B) transactions are recorded as necessary to permit preparation of
financial statements in conformity with generally accepted accounting principles and to maintain
accountability for assets; (C) access to assets is permitted only in accordance with managements
general or specific authorization; and (D) the recorded accountability for assets is compared with
existing assets at reasonable intervals and appropriate action is taken with respect to any
differences. Except as described in the Registration Statement, the General Disclosure Package or
in the Prospectus, since January 1, 2010, there has been no change in the Companys internal
control over financial reporting that has materially affected, or is reasonably likely to
materially affect, the Companys internal control over financial reporting.
(bb) The Companys Board of Directors has validly appointed an audit committee whose
composition satisfies the requirements of the rules and regulations of the NYSE Amex stock exchange
and the Board of Directors or audit committee has adopted a charter that satisfies the requirements
of the rules and regulations of the NYSE Amex stock exchange. The audit committee has reviewed the
adequacy of its charter within the past twelve months. Neither the Board of Directors nor the
audit committee has been informed, nor is any director of the Company aware, of: (i) any
significant deficiencies and material weaknesses in the design or operation of internal control
over financial reporting which are reasonably likely to adversely affect the Companys ability to
record, process, summarize and report financial information; or (ii) any fraud, whether or not
material, that involves management or other employees who have a significant role in the Companys
internal control over financial reporting.
(cc) Neither the Company nor, to the Companys knowledge, any of its Affiliates has taken,
directly or indirectly, any action which constitutes or is designed to cause or result in, or which
could reasonably be expected to constitute, cause or result in, the stabilization or manipulation
of the price of any security to facilitate the sale or resale of the Securities.
(dd) Neither the Company nor, to the Companys knowledge, any of its Affiliates has, prior to
the date hereof, made any offer or sale of any securities which are
-14-
Maxim Group LLC
May 17, 2010
Page 15 of 44
required to be integrated pursuant to the Securities Act or the Rules and Regulations with
the offer and sale of the Securities pursuant to the Registration Statement. Except as disclosed
in the Registration Statement, the General Disclosure Package, the Prospectus, neither Company nor
any of its Affiliates has sold or issued any Relevant Security during the six-month period
preceding the date of the Prospectus, including but not limited to any sales pursuant to Rule 144A
or Regulation D or S under the Securities Act, other than Common Shares issued pursuant to employee
benefit plans, qualified stock option plans or the employee compensation plans or pursuant to
outstanding options, rights or warrants as described in the Registration Statement, the General
Disclosure Package and the Prospectus.
(ee) All information contained in the questionnaires completed by each of the Companys
officers and directors immediately prior to the Offering and provided to the Representative as well
as in the biographies of such individuals in the Registration Statement is true and correct in all
material respects and the Company has not become aware of any information which would cause the
information disclosed in the questionnaires completed by the directors and officers to become
inaccurate or incorrect.
(ff) No director or officer of the Company is subject to any non-competition agreement or
non-solicitation agreement with any employer or prior employer which could materially affect his
ability to be and act in his respective capacity of the Company.
(gg) Except as disclosed in the Registration Statement, the General Disclosure Package and the
Prospectus, no holder of any Relevant Security has any rights to require registration of any
Relevant Security as part or on account of, or otherwise in connection with, the offer and sale of
the Securities contemplated hereby, that have not either been fully complied with by the Company or
effectively waived by the holders thereof, and any such waivers remain in full force and effect.
(hh) The conditions for use of Form S-1 to register the Offering under the Securities Act, as
set forth in the General Instructions to such Form, have been satisfied.
(ii) The Company is not and, at all times up to and including consummation of the transactions
contemplated by this Agreement, and after giving effect to application of the net proceeds of the
Offering, will not be, subject to registration as an investment company under the Investment
Company Act of 1940, as amended, and is not and will not be an entity controlled by an
investment company within the meaning of such act.
(jj) No relationship, direct or indirect, exists between or among any of the Company or any
Affiliate of the Company, on the one hand, and any director, officer, shareholder, customer or
supplier of the Company or any affiliate of the Company, on the other hand, which is required by
the Securities Act or the Rules and Regulations to be described in the Registration Statement or
the Prospectus which is not so described as required. There are no outstanding loans, advances
(except normal advances for business expenses in the ordinary course of business) or guarantees of
indebtedness by the Company to or for the benefit of any of
-15-
Maxim Group LLC
May 17, 2010
Page 16 of 44
the officers or directors of the Company or any of their respective family members, except as
described in the Registration Statement, the General Disclosure Package, and the Prospectus. The
Company has not, in violation of the Sarb-Ox directly or indirectly extended or maintained credit,
arranged for the extension of credit, or renewed an extension of credit, in the form of a personal
loan to or for any director or executive officer of the Company.
(kk) The Company is in material compliance with the applicable provisions of Sarb-Ox and the
Rules and Regulations promulgated thereunder and related or similar rules and regulations
promulgated by the NYSE Amex stock exchange or any other governmental or self regulatory entity or
agency, except for such violations which, singly or in the aggregate, would not have a Material
Adverse Effect. Without limiting the generality of the foregoing: (i) all members of the Companys
board of directors who are required to be independent (as that term is defined under applicable
laws, rules and regulations), including, without limitation, all members of the audit committee of
the Companys board of directors, meet the qualifications of independence as set forth under
applicable laws, rules and regulations, (ii) all members of the audit committee of the Companys
board of directors are able to read and understand fundamental financial statements, including a
companys balance sheet, income statement, and cash flow statement, and (iii) at least one member
of the audit committee of the Companys board of directors is financially sophisticated (as that
term is defined under the NYSE Amex Company Guide). In addition, the audit committee of the
Companys board of directors has at least one member that has been determined to be an audit
committee financial expert (as that term is defined under the rules and regulations of the SEC).
(ll) Except as disclosed in the Registration Statement, the General Disclosure Package and the
Prospectus, there are no contracts, agreements or understandings between the Company and any Person
that would give rise to a valid claim against the Company or any Underwriter for a brokerage
commission, finders fee or other like payment in connection with the transactions contemplated by
this Agreement or, to the Companys knowledge, any arrangements, agreements, understandings,
payments or issuance with respect to the Company or any of its officers, directors, shareholders,
partners, employees, or Affiliates that may affect the Underwriters compensation as determined by
FINRA.
(mm) The Company owns or leases all such properties as are necessary to the conduct of its
business as presently operated and as proposed to be operated as described in the Registration and
the Prospectus. The Company has good and marketable title in fee simple to all real property and
good and marketable title to all personal property owned by them, in each case free and clear of
all Liens except such as are described in the Registration Statement, the General Disclosure
Package and the Prospectus or such as do not (individually or in the aggregate) materially affect
the business or prospects of the Company. Any real property and buildings held under lease or
sublease by the Company are held by under valid, subsisting and enforceable leases with such
exceptions as are not material to, and do not interfere with, the use made and proposed to be made
of such property and buildings by the Company. The Company has not received any notice of any
claim adverse to its ownership of any real or personal property or of
-16-
Maxim Group LLC
May 17, 2010
Page 17 of 44
any claim against the continued possession of any real property, whether owned or held under
lease or sublease by the Company.
(nn) The Company: (i) owns or possesses adequate right to use all patents, patent
applications, trademarks, service marks, trade names, trademark registrations, service mark
registrations, copyrights, licenses, formulae, customer lists, and know-how and other intellectual
property (including trade secrets and other unpatented or unpatentable proprietary or confidential
information, systems or procedures,
Intellectual Property
) necessary for the conduct of its
businesses as being conducted and as described in the Registration Statement, the General
Disclosure and Prospectus and (ii) has no knowledge that the conduct of its businesses does or will
conflict with, and it has not received any notice of any claim of conflict with, any such right of
others. To the Companys knowledge, all material technical information developed by and belonging
to the Company which has not been patented (including, without limitation, the Internet-based,
proprietary referral system referred to in the Prospectus) has been kept confidential so as, among
other things, all such information may be deemed proprietary to the Company. Except as set forth
in the Registration Statement, the General Disclosure Package or the Prospectus, the Company has
not granted or assigned to any other Person any right to sell the current products and services of
the Company or those products and services described in the Registration Statement and Prospectus.
To the Companys best knowledge, there is no infringement by third parties of any such Intellectual
Property; there is no pending or, to the Companys knowledge, threatened action, suit, proceeding
or claim by others challenging the Companys rights in or to any such Intellectual Property, and
the Company is unaware of any facts which would form a reasonable basis for any such claim; and
there is no pending or, to the Companys knowledge, threatened action, suit, proceeding or claim by
others that the Company infringes or otherwise violates any patent, trademark, copyright, trade
secret or other proprietary rights of others, and the Company is unaware of any other fact which
would form a reasonable basis for any such claim.
(oo) The agreements and documents described in the Registration Statement, the General
Disclosure Package and the Prospectus conform to the descriptions thereof contained therein and
there are no agreements or other documents required to be described in the Registration Statement,
the General Disclosure Package or the Prospectus or to be filed with the Commission as exhibits to
the Registration Statement, that have not been so described or filed. Each agreement or other
instrument (however characterized or described) to which the Company is a party or by which its
property or business is or may be bound or affected and (i) that is referred to in the Registration
Statement, the General Disclosure Package or the Prospectus or attached as an exhibit thereto, or
(ii) is material to the Companys business, has been duly and validly executed by the Company, is
in full force and effect in all material respects and is enforceable against the Company and, to
the Companys knowledge, the other parties thereto, in accordance with its terms, except (x) as
such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws
affecting creditors rights generally, (y) as enforceability of any indemnification or contribution
provision may be limited under the foreign, federal and state securities laws, and (z) that the
remedy of specific performance and injunctive and other forms of equitable relief may be subject to
the equitable defenses and to the discretion
-17-
Maxim Group LLC
May 17, 2010
Page 18 of 44
of the court before which any proceeding therefor may be brought, and none of such agreements
or instruments has been assigned by the Company, and neither the Company nor, to the Companys
knowledge, any other party is in breach or default thereunder and, to the Companys knowledge, no
event has occurred that, with the lapse of time or the giving of notice, or both, would constitute
a breach or default thereunder, except for such breaches as would not, individually or in the
aggregate, reasonably be expected to result in a Material Adverse Effect. To the Companys
knowledge, performance by the Company of the material provisions of such agreements or instruments
will not result in a violation of any existing applicable law, rule, regulation, judgment, order or
decree of any governmental agency or court, domestic or foreign, having jurisdiction over the
Company or any of its assets or businesses, including, without limitation, those relating to
environmental laws and regulations.
(pp) The disclosures in the Registration Statement, the General Disclosure Package and the
Prospectus concerning the effects of foreign, federal, state and local regulation on the Companys
business as currently contemplated are correct in all material respects and do not omit to state a
material fact necessary to make the statements therein, in light of the circumstances in which they
were made, not misleading.
(qq) The Company has accurately prepared and timely filed all federal, state, foreign, and
other tax returns that are required to be filed by it (or properly filed extensions with respect
thereto) and has paid or made provision for the payment of all taxes, assessments, governmental or
other similar charges, including without limitation, all sales and use taxes and all taxes which
the Company is obligated to withhold from amounts owing to employees, creditors and third parties,
with respect to the periods covered by such tax returns (whether or not such amounts are shown as
due on any tax return). No deficiency assessment with respect to a proposed adjustment of the
Companys federal, state, local or foreign taxes is pending or, to the Companys knowledge,
threatened. The accruals and reserves on the books and records of the Company in respect of tax
liabilities for any taxable period not finally determined are adequate to meet any assessments and
related liabilities for any such period and, since the date of the Companys most recent audited
financial statements, the Company has not incurred any liability for taxes other than in the
ordinary course of its business. There is no tax lien, whether imposed by any federal, state,
foreign or other taxing authority, outstanding against the assets, properties or business of the
Company.
(rr) No labor disturbance by the employees of the Company currently exists or, to the
Companys knowledge, is likely to occur.
(ss) The Company has at all times operated its business in material compliance with all
Environmental Laws, and no material expenditures are or will be required to comply therewith. The
Company has not received any notice or communication that relates to or alleges any actual or
potential violation or failure to comply with any Environmental Laws that will result in a Material
Adverse Effect. As used herein, the term
Environmental Laws
means all applicable laws and
regulations, including any licensing, permits or reporting requirements, and any action by a
federal state or local government entity pertaining to the protection of the
-18-
Maxim Group LLC
May 17, 2010
Page 19 of 44
environment, protection of public health, protection of worker health and safety, or the
handling of hazardous materials, including without limitation, the Clean Air Act, 42 U.S.C. § 7401,
et seq., the Comprehensive Environmental Response, Compensation and Liability Act of 1980, 42
U.S.C. § 9601, et seq., the Federal Water Pollution Control Act, 33 U.S.C. § 1321, et seq., the
Hazardous Materials Transportation Act, 49 U.S.C. § 1801, et seq., the Resource Conservation and
Recovery Act, 42 U.S.C. § 690-1, et seq., and the Toxic Substances Control Act, 15 U.S.C. § 2601,
et seq.
(tt) Except as set forth in the Registration Statement, the General Disclosure Package or the
Prospectus, the Company is not a party to an employee benefit plan, as defined in Section 3(3) of
the Employee Retirement Income Security Act of 1974 (
ERISA
) which: (i) is subject to any
provision of ERISA and (ii) is currently maintained, administered or contributed to by the Company
and covers any employee or former employee of the Company or any ERISA Affiliate (as defined
hereafter). These plans are referred to collectively herein as the
Employee Plans
. For purposes
of this Section,
ERISA Affiliate
of any person or entity means any other person or entity which,
together with that person or entity, could be treated as a single employer under Section 414(m) of
the Internal Revenue Code of 1986, as amended (the
Code
), or is an affiliate, whether or not
incorporated, as defined in Section 407(d)(7) of ERISA, of the person or entity.
(uu) The Registration Statement, the General Disclosure Package and the Prospectus identify
each employment, severance or other agreement providing material terms of employment and each
material plan or arrangement providing for insurance coverage (including any self-insured
arrangements), workers compensation, disability benefits, severance benefits, supplemental
unemployment benefits, vacation benefits, retirement benefits or for deferred compensation,
profit-sharing, bonuses, stock options, stock appreciation or other forms of incentive
compensation, or post-retirement insurance, compensation or benefits (other than regular salary and
wages) which: (i) is not an Employee Plan, (ii) is currently effective, maintained or contributed
to, as the case may be, by the Company or any of its ERISA Affiliates, and (iii) is by and between
any employee or former employee of the Company or any of its ERISA Affiliates. These contracts,
plans and arrangements are referred to collectively in this Agreement as the
Benefit
Arrangements
. Each Benefit Arrangement has been maintained in substantial compliance with its
terms and with requirements prescribed by any and all statutes, orders, rules and regulations that
are applicable to that Benefit Arrangement.
(vv) Except as set forth in the Registration Statement, the General Disclosure Package or the
Prospectus, there is no liability in respect of post-retirement health and medical benefits for
retired employees of the Company or any of its ERISA Affiliates other than medical benefits
required to be continued under applicable law. With respect to any of the Companys Employee Plans
which are group health plans under Section 4980B of the Code and Section 607(1) of ERISA, there
has been material compliance with all requirements imposed there under such that the Company or any
of its ERISA Affiliates have no (and will not incur any) loss, assessment, tax penalty, or other
sanction with respect to any such plan, except for such losses,
-19-
Maxim Group LLC
May 17, 2010
Page 20 of 44
assessments, penalties or other sanctions as would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect. .
(ww) Except as set forth in the Registration Statement, the General Disclosure Package or the
Prospectus, the Company is not a party to or subject to any employment contract or arrangement
providing for annual future compensation, or the opportunity to earn annual future compensation
(whether through fixed salary, bonus, commission, options or otherwise) of more than $120,000 to
any officer, consultant, director or employee.
(xx) The execution of this Agreement, the Representatives Warrants or consummation of the
Offering does not constitute a triggering event under any Employee Plan or any other employment
contract, whether or not legally enforceable, which (either alone or upon the occurrence of any
additional or subsequent event) will or may result in any payment (of severance pay or otherwise),
acceleration, increase in vesting, or increase in benefits to any current or former participant,
employee or director of the Company other than an event that is not material to the financial
condition or business of the Company, either individually or taken as a whole.
(yy) No prohibited transaction (as defined in either Section 406 of the ERISA or Section
4975 of Code), accumulated funding deficiency (as defined in Section 302 of ERISA) or other event
of the kind described in Section 4043(b) of ERISA (other than events with respect to which the
30-day notice requirement under Section 4043 of ERISA has been waived) has occurred with respect to
any employee benefit plan for which the Company would have any liability; each employee benefit
plan of the Company is in compliance in all material respects with applicable law, including
(without limitation) ERISA and the Code; the Company has not incurred and does not expect to incur
liability under Title IV of ERISA with respect to the termination of, or withdrawal from any
pension plan; and each employee benefit plan of the Company that is intended to be qualified
under Section 401(a) of the Code is so qualified and nothing has occurred, whether by action or by
failure to act, which could cause the loss of such qualification.
(zz) Neither the Company nor, to the Companys knowledge, any of its employees or agents has
at any time during the last five (5) years: (i) made any unlawful contribution to any candidate for
foreign office, or failed to disclose fully any contribution in violation of law, or (ii) made any
payment to any federal or state governmental officer or official or other Person charged with
similar public or quasi-public duties, other than payments that are not prohibited by the laws of
the United States of any jurisdiction thereof.
(aaa) The Company is in compliance with all applicable foreign and U.S. laws, rules,
regulations, ordinances, directives, judgments, decrees and orders (including, without limitation,
all securities and tax laws, rules and regulations), except for such non-compliance as would not
reasonably be expected to have a Material Adverse Effect.
-20-
Maxim Group LLC
May 17, 2010
Page 21 of 44
(bbb) The operations of the Company are and have been conducted at all times in compliance
with applicable financial record keeping and reporting requirements and money laundering statutes
of the United States and, to the Companys knowledge, all other jurisdictions to which the Company
is subject, the rules and regulations thereunder and any related or similar rules, regulations or
guidelines, issued, administered or enforced by any applicable governmental agency (collectively,
the
Money Laundering Laws
) and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving the Company with respect to the
Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.
(ccc) Neither the Company nor, to the knowledge of the Company, any director, officer, agent,
employee or Affiliate is currently subject to any U.S. sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department (
OFAC
); and the Company will not directly
or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available
such proceeds to any joint venture partner or other person or entity, for the purpose of financing
the activities of any person currently subject to any U.S. sanctions administered by OFAC.
(ddd) As used in this Agreement, references to matters being
material
with respect to the
Company shall mean a material event, change, condition, status or effect related to the condition
(financial or otherwise), properties, assets (including intangible assets), liabilities, business,
prospects, operations or results of operations of the Company, either individually or taken as a
whole, as the context requires.
(eee) As used in this Agreement, the term
knowledge of the Company
(or similar language)
shall mean the knowledge of the officers of the Company who are named in the Prospectus, with the
assumption that such officers shall have made reasonable and diligent inquiry of the matters
presented (with reference to what is customary and prudent for the applicable individuals in
connection with the discharge by the applicable individuals of their duties as officers, directors
or managers of the Company).
Any certificate signed by or on behalf of the Company and delivered to the Underwriters or to
Lowenstein Sandler PC (
Underwriters Counsel
) shall be deemed to be a representation and warranty
by the Company to each Underwriter listed on
Schedule A
hereto as to the matters covered
thereby.
3.
Reserved
.
4.
Offering
. Upon authorization of the release of the Firm Units by the
Representative, the Underwriters propose to offer the Units for sale to the public upon the terms
and conditions set forth in the Prospectus.
5.
Covenants of the Company
. The Company acknowledges, covenants and agrees with the
Underwriters that:
-21-
Maxim Group LLC
May 17, 2010
Page 22 of 44
(a) The Registration Statement and any amendments thereto have been declared effective, and if
Rule 430A is used or the filing of the Prospectus is otherwise required under Rule 424(b), the
Company will file the Prospectus (properly completed if Rule 430A has been used) pursuant to Rule
424(b) within the prescribed time period and will provide evidence satisfactory to the
Representative of such timely filing.
(b) During the period beginning on the date hereof and ending on the later of the Closing Date
or such date, as in the opinion of counsel for the Underwriter, the Prospectus is no longer
required by law to be delivered (or in lieu thereof the notice referred to in Rule 173(a) under the
Securities Act is no longer required to be provided), in connection with sales by an underwriter or
dealer (the
Prospectus Delivery Period
), prior to amending or supplementing the Registration
Statement, the General Disclosure Package or the Prospectus, the Company shall furnish to the
Underwriter for review a copy of each such proposed amendment or supplement, and the Company shall
not file any such proposed amendment or supplement to which the Underwriter reasonably object
within 36 hours of delivery thereof to the Underwriter and its counsel.
(c) After the date of this Agreement, the Company shall promptly advise the Underwriter in
writing (i) of the receipt of any comments of, or requests for additional or supplemental
information from, the Commission, (ii) of the time and date of any filing of any post-effective
amendment to the Registration Statement or any amendment or supplement to any Prospectus, the
General Disclosure Package or the Prospectus, (iii) of the time and date that any post-effective
amendment to the Registration Statement becomes effective and (iv) of the issuance by the
Commission of any stop order suspending the effectiveness of the Registration Statement or any
post-effective amendment thereto or of any order preventing or suspending its use or the use of any
Prospectus, the General Disclosure Package, the Prospectus or any Issuer-Represented Free Writing
Prospectus, or of any proceedings to remove, suspend or terminate from listing the Common Shares
from any securities exchange upon which it is listed for trading, or of the threatening or
initiation of any proceedings for any of such purposes. If the Commission shall enter any such
stop order at any time, the Company will use its reasonable efforts to obtain the lifting of such
order at the earliest possible moment. Additionally, the Company agrees that it shall comply with
the provisions of Rules 424(b), 430A and 430B, as applicable, under the Securities Act and will use
its reasonable efforts to confirm that any filings made by the Company under Rule 424(b) or Rule
433 were received in a timely manner by the Commission (without reliance on Rule 424(b)(8) or Rule
164(b)).
(d) (i) During the Prospectus Delivery Period, the Company will comply as far as it is able
with all requirements imposed upon it by the Securities Act, as now and hereafter amended, and by
the Rules and Regulations, as from time to time in force, and by the Exchange Act so far as
necessary to permit the continuance of sales of or dealings in the Securities as contemplated by
the provisions hereof, the General Disclosure Package, and the Registration Statement and the
Prospectus. If during such period any event occurs as a result of which the Prospectus (or if the
Prospectus is not yet available to prospective purchasers, the General
-22-
Maxim Group LLC
May 17, 2010
Page 23 of 44
Disclosure Package) would include an untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the light of the circumstances then
existing, not misleading, or if during such period it is necessary or appropriate in the opinion of
the Company or its counsel or the Underwriter or counsel to the Underwriter to amend the
Registration Statement or supplement the Prospectus (or if the Prospectus is not yet available to
prospective purchasers, the General Disclosure Package) to comply with the Securities Act or to
file under the Exchange Act any document which would be deemed to be incorporated by reference in
the Prospectus to comply with the Securities Act or the Exchange Act, the Company will promptly
notify the Underwriter and will amend the Registration Statement or supplement the Prospectus (or
if the Prospectus is not yet available to prospective purchasers, the General Disclosure Package)
or file such document (at the expense of the Company) so as to correct such statement or omission
or effect such compliance.
(ii) If at any time following issuance of an Issuer-Represented Free Writing Prospectus there
occurred or occurs an event or development as a result of which such Issuer-Represented Free
Writing Prospectus conflicted or would conflict with the information contained in the Registration
Statement, the Statutory Prospectus or the Prospectus or included or would include an untrue
statement of a material fact or omitted or would omit to state a material fact necessary to make
the statements therein, in the light of the circumstances prevailing at that subsequent time, not
misleading, the Company has promptly notified or promptly will notify the Underwriter and has
promptly amended or will promptly amend or supplement, at its own expense, such Issuer-Represented
Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.
(e) The Company will promptly deliver to the Underwriters and Underwriters Counsel a signed
copy of the Registration Statement, as initially filed and all amendments thereto, including all
consents and exhibits filed therewith, and will maintain in the Companys files manually signed
copies of such documents for at least five (5) years after the date of filing thereof. The Company
will promptly deliver to each of the Underwriters such number of copies of any Preliminary
Prospectus, the Prospectus, the Registration Statement, and all amendments of and supplements to
such documents, if any, and all documents which are exhibits to the Registration Statement and
Prospectus or any amendment thereof or supplement thereto, as the Underwriters may reasonably
request. The Company will promptly deliver to each of the Underwriters a duly executed Warrant
Agreement, in substantially the form attached as
Annex II
. Prior to 2:00 P.M., New York
time, on the Business Day next succeeding the date of this Agreement and from time to time
thereafter, the Company will furnish the Underwriters with copies of the Prospectus in New York
City in such quantities as the Underwriters may reasonably request.
(f) The Company consents to the use and delivery of the Preliminary Prospectus by the
Underwriters in accordance with Rule 430 and Section 5(b) of the Securities Act.
-23-
Maxim Group LLC
May 17, 2010
Page 24 of 44
(g) If the Company elects to rely on Rule 462(b) under the Securities Act, the Company shall
both file a Rule 462(b) Registration Statement with the Commission in compliance with Rule 462(b)
and pay the applicable fees in accordance with Rule 111 of the Act by the earlier of: (i) 10:00
p.m., New York City time, on the date of this Agreement, and (ii) the time that confirmations are
given or sent, as specified by Rule 462(b)(2).
(h) The Company will use its best efforts, in cooperation with the Representative to qualify
the Securities for offering and sale under the securities laws relating to the offering or sale of
the Securities of such jurisdictions, domestic or foreign, as the Representative may designate and
to maintain such qualification in effect for so long as required for the distribution thereof;
except that in no event shall the Company be obligated in connection therewith to qualify as a
foreign corporation or to execute a general consent to service of process.
(i) The Company will make generally available to its security holders as soon as practicable,
but in any event not later than fifteen (15) months after the end of the Companys current fiscal
quarter, an earnings statement (which need not be audited) covering a twelve (12) month period that
shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 of the Rules and
Regulations (it being understood that filing such statement on EDGAR shall satisfy this
requirement).
(j) Except with respect to (i) securities of the Company which may be issued in connection
with an acquisition of another entity (or the assets thereof), (ii) the issuance of securities of
the Company intended to provide the Company with proceeds to acquire anther entity (or the assets
thereof), or (iii) the issuance of securities under the Companys stock option plans in effect from
time to time, during the ninety (90) days following the Closing Date, the Company or any successor
to the Company shall not undertake any public or private offerings of any equity securities of the
Company (including equity-linked securities) without the written consent of the Representative,
which consent shall not be unreasonably withheld.
(k) The Company will deliver to the Representative the agreements of the individuals listed on
Schedule B
hereto (the
Lock-Up Parties
) to the foregoing effect prior to the Closing
Date, which agreements shall be substantially in the form attached hereto as
Annex I
.
(l) If the Company fails to maintain the listing of its Common Shares on a national securities
exchange (as defined under the rules and regulations of the SEC), for a period of three (3) years
from the effective date of the Registration Statement, the Company, at its expense, shall obtain
and keep current a listing in the Standard & Poors Corporation Records Services or the Moodys
Industrial Manual; provided that Moodys OTC Industrial Manual is not sufficient for these
purposes.
(m) During the period of three (3) years from the effective date of the Registration
Statement, the Company will furnish to the Underwriters copies of all reports or other
communications (financial or other) furnished to security holders or from time to time published or
publicly disseminated by the Company, and will deliver to the Underwriters: (i) as
-24-
Maxim Group LLC
May 17, 2010
Page 25 of 44
soon as they are available, copies of any reports, financial statements and proxy or
information statements furnished to or filed with the Commission or any national securities
exchange on which any class of securities of the Company is listed; and (ii) such additional
information concerning the business and financial condition of the Company as the Representative
may from time to time reasonably request (such financial information to be on a consolidated basis
to the extent the accounts of the Company are consolidated in reports furnished to its security
holders generally or to the Commission). The obligations of this Section 5(m) shall be deemed
satisfied if the Company files or furnishes such information on EDGAR.
(n) The Company will not issue press releases or engage in any other publicity, without the
Representatives prior written consent, for a period ending at 5:00 p.m. Eastern time on the first
Business Day following the forty-fifth (45th) day following the Closing Date, other than normal and
customary releases issued in the ordinary course of the Companys business. The failure of the
Representative to object to such press release within 24 hours shall be deemed to constitute
consent for this purpose.
(o) The Company will apply the net proceeds from the sale of the Securities as set forth under
the caption Use of Proceeds in the Prospectus.
(p) The Company will use its commercially reasonable efforts to effect and maintain the
listing of the Securities on the NYSE Amex stock exchange for at least three (3) years after the
Closing Date.
(q) The Company, during the period when the Prospectus is required to be delivered under the
Securities Act or the Exchange Act, will file all documents required to be filed with the
Commission pursuant to the Securities Act, the Exchange Act and the Rules and Regulations within
the time periods required thereby, including any extensions of the time period required for such
filings pursuant to timely filed notices under Rule 12b-25 under the Exchange Act.
(r) The Company will not take, and will use commercially reasonable efforts to cause its
Affiliates not to take, directly or indirectly, any action which constitutes or is designed to
cause or result in, or which could reasonably be expected to constitute, cause or result in, the
stabilization or manipulation of the price of any security to facilitate the sale or resale of the
Securities.
(s) The Company shall cause to be prepared and delivered to the Representative, at its
expense, within one (1) Business Day from the effective date of this Agreement, an Electronic
Prospectus to be used by the Underwriters in connection with the Offering. As used herein, the
term
Electronic Prospectus
means a form of prospectus, and any amendment or supplement thereto,
that meets each of the following conditions: (i) it shall be encoded in an electronic format,
satisfactory to the Representative, that may be transmitted electronically by the other
Underwriters to offerees and purchasers of the Securities for at least the period during which a
Prospectus relating to the Securities is required to be delivered under
-25-
Maxim Group LLC
May 17, 2010
Page 26 of 44
the Securities Act; (ii) it shall disclose the same information as the paper prospectus and
prospectus filed pursuant to EDGAR, except to the extent that graphic and image material cannot be
disseminated electronically, in which case such graphic and image material shall be replaced in the
electronic prospectus with a fair and accurate narrative description or tabular representation of
such material, as appropriate; and (iii) it shall be in or convertible into a paper format or an
electronic format, satisfactory to the Representative, that will allow recipients thereof to store
and have continuously ready access to the prospectus at any future time, without charge to such
recipients (other than any fee charged for subscription to the Internet as a whole and for on-line
time).
(t) The Company represents and agrees that, unless it obtains the prior written consent of the
Representative, and the Representative represents and agrees that, unless it obtains the prior
written consent of the Company, it has not made and will not make any offer relating to the
Securities that would constitute an issuer free writing prospectus, as defined in Rule 433 under
the Securities Act, or that would otherwise constitute a free writing prospectus, as defined in
Rule 405 under the Securities Act, required to be filed with the Commission; provided that the
prior written consent of the parties hereto shall be deemed to have been given in respect of the
free writing prospectuses included in
Schedule C
. Any such free writing prospectus
consented to by the Company and the Representative is hereinafter referred to as a Permitted Free
Writing Prospectus. The Company represents that it has treated or agrees that it will treat each
Permitted Free Writing Prospectus as an issuer free writing prospectus, as defined in Rule 433,
and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free
Writing Prospectus, including timely Commission filing where required, legending and record
keeping.
(u) For a period of three (3) years from the Closing Date the Company agrees to hold all
special and annual meetings of its shareholders within the United States.
6.
Consideration; Payment of Expenses
.
(a) In consideration of the services to be provided for hereunder, the Company shall pay to
the Underwriters or their respective designees their pro rata portion (based on the Securities
purchased) of the following compensation with respect to the Shares which they are offering:
(i) An underwriting discount of eight percent (8%) of the gross proceeds of the Offering
(exclusive of any gross proceeds that originate from Sigma Tau
Finanziaria, S.p.A. or any of its
Affiliates (collectively, Sigma Tau) with respect to which amount no underwriting discount shall
be payable); and
(ii) The Representatives Warrants.
(b) If the Offering results in net proceeds to the Company (after underwriting discounts and
the payment of the Company expenses related to the Offering) of at least $5.0
-26-
Maxim Group LLC
May 17, 2010
Page 27 of 44
million, the Company grants the Representative the right of participation to act as lead
managing underwriter and book runner or minimally as co-lead manager and co-book runner or co-lead
placement agent with at least fifty percent (50%) of the economics; or in the case of a
three-handed deal thirty-three percent (33%) of the economics for a period of six (6) months from
the Closing Date, for any and all future public and private equity offerings and any convertible
debt offerings, excluding ordinary course of business financings such as bank lines of credit,
accounts receivable, factoring and financing generated by the Company or any successor to or any
subsidiary of the Company. The Company shall provide written notice to Representative with terms of
such offering and if Representative fails to accept in writing any such proposal for such public or
private sale within twenty (20) days after receipt of a written notice from the Company containing
such proposal, then Representative will have no claim or right with respect to any such sale
contained in any such notice.
(c) The Representative reserves the right to reduce any item of compensation or adjust the
terms thereof as specified herein in the event that a determination shall be made by FINRA to the
effect that the Underwriters aggregate compensation is in excess of FINRA Rules or that the terms
thereof require adjustment.
(d) Whether or not the transactions contemplated by this Agreement, the Registration Statement
and the Prospectus are consummated or this Agreement is terminated, the Company hereby agrees to
pay all costs and expenses incident to the performance of its obligations hereunder, including the
following:
(i) all expenses in connection with the preparation, printing, formatting for EDGAR and filing
of the Registration Statement, any Preliminary Prospectus and the Prospectus and any and all
amendments and supplements thereto and the mailing and delivering of copies thereof to the
Underwriters and dealers;
(ii) all fees and expenses in connection with the filing of Corporate Offerings Business &
Regulatory Analysis (
COBRADesk
) filings with FINRA;
(iii) all fees and expenses in connection with filing of the Registration Statement and
Prospectus with the Commission;
(iv) the fees, disbursements and expenses of the Companys counsel and accountants in
connection with the registration of the Securities under the Securities Act and the Offering;
(v) all expenses in connection with the qualifications of the Shares for offering and sale
under state or foreign securities or blue sky laws, including the fees and disbursements of counsel
for the Underwriters in connection with such qualification or any analysis in connection with analysis of blue sky laws and in connection with any blue by
survey undertaken by such counsel;
-27-
Maxim Group LLC
May 17, 2010
Page 28 of 44
(vi) all fees and expenses in connection with listing the Securities on the NYSE Amex stock
exchange;
(vii) all travel expenses of the Companys officers and employees and any other expense of the
Company incurred in connection with attending or hosting meetings with prospective purchasers of
the Units (
Road Show Expenses
);
(viii) any stock transfer taxes incurred in connection with this Agreement or the Offering
(ix) the cost of preparing stock certificates representing the Securities;
(x) the cost and charges of any transfer agent or registrar for the Securities;
(xi) any cost and expenses in conducting satisfactory due diligence investigation and analysis
of the Companys officers, directors, employees, and affiliates; and
(xii) all other costs and expenses incident to the performance of the Company obligations
hereunder which are not otherwise specifically provided for in this Section 6.
(e) It is understood, however, that except as provided in this Section, and Sections 7, 8 and
12(d) hereof, the Underwriters will pay all of their own costs and expenses, including the fees of
their counsel. Notwithstanding anything to the contrary in this Section 6, in the event that this
Agreement is terminated pursuant to Section 12(b) hereof or subsequent to a Material Adverse
Change, the Company will pay all out-of-pocket expenses of the Underwriters (including but not
limited to fees and disbursements of counsel to the Underwriters) incurred in connection herewith
which shall be limited to expenses which are actually incurred as allowed under FINRA Rule 5110.
7.
Conditions of Underwriters Obligations
. The obligations of the Underwriters to
purchase and pay for the Firm Units or Option Units, as the case may be, as provided herein shall
be subject to: (i) the accuracy of the representations and warranties of the Company herein
contained, as of the date hereof and as of the Closing Date (ii) the absence from any certificates,
opinions, written statements or letters furnished to the Representative or to Underwriters Counsel
pursuant to this Section 7 of any misstatement or omission (iii) the performance by the Company of
its obligations hereunder, and (iv) each of the following additional conditions. For purposes of
this Section 7, the terms Closing Date and Closing shall refer to the Closing Date for the Firm
Units or Option Units, as the case may be, and each of the foregoing and following conditions must
be satisfied as of each Closing.
(a) The Registration Statement shall have become effective and all necessary regulatory or
listing approvals shall have been received not later than 5:30 P.M., New York time,
-28-
Maxim Group LLC
May 17, 2010
Page 29 of 44
on the date of this Agreement, or at such later time and date as shall have been consented to
in writing by the Representative. If the Company shall have elected to rely upon Rule 430A under
the Securities Act, the Prospectus shall have been filed with the Commission in a timely fashion in
accordance with the terms hereof and a form of the Prospectus containing information relating to
the description of the Securities and the method of distribution and similar matters shall have
been filed with the Commission pursuant to Rule 424(b) within the applicable time period; and, at
or prior to the Closing Date or the actual time of the Closing, no stop order suspending the
effectiveness of the Registration Statement or any part thereof, or any amendment thereof, nor
suspending or preventing the use of the General Disclosure Package, the Prospectus or any Issuer
Free Writing Prospectus shall have been issued; no proceedings for the issuance of such an order
shall have been initiated or threatened; any request of the Commission for additional information
(to be included in the Registration Statement, the General Disclosure Package, the Prospectus, any
Issuer Free Writing Prospectus or otherwise) shall have been complied with to the Representatives
satisfaction; and FINRA shall have raised no objection to the fairness and reasonableness of the
underwriting terms and arrangements.
(b) The Representative shall not have reasonably determined, and advised the Company, that the
Registration Statement, the General Disclosure Package or the Prospectus, or any amendment thereof
or supplement thereto, or any Issuer Free Writing Prospectus, contains an untrue statement of fact
which, in the Representatives reasonable opinion, is material, or omits to state a fact which, in
the Representatives reasonable opinion, is material and is required to be stated therein or
necessary to make the statements therein not misleading.
(c) The Representative shall have received the favorable written opinion of Cooley LLP, United
States legal counsel for the Company, dated as of the Closing Date addressed to the Underwriters in
the form and substance reasonably acceptable to the Representative.
(d) The Representative shall have received the favorable written opinion of Lowenstein Sandler
PC, legal counsel for the Underwriters, dated as of the Closing Date addressed to the Underwriters
in the form and substance reasonably acceptable to the Representative.
(e) The Representative shall have received a certificate of the Chief Executive Officer and
Chief Financial Officer of the Company, dated as of each Closing Date to the effect that: (i) the
condition set forth in subsection (a) of this Section 7 has been satisfied, (ii) as of the date
hereof and as of the applicable Closing Date, the representations and warranties of the Company set
forth in Sections 1 and 2 hereof are accurate, (iii) as of the applicable Closing Date, all
agreements, conditions and obligations of the Company to be performed or complied with hereunder on
or prior thereto have been duly performed or complied with, (iv) subsequent to the respective dates
of the Prospectus and the General Disclosure Package, the Company has not sustained any Material
Adverse Effect, (v) no stop order suspending the effectiveness of the Registration Statement or any
post-effective amendment thereof has been issued and, to the Companys knowledge, no proceedings
therefor have been initiated or threatened by the
-29-
Maxim Group LLC
May 17, 2010
Page 30 of 44
Commission, (vi) there are no pro forma or as adjusted financial statements that are required
to be included or incorporated by reference in the Registration Statement and the Prospectus
pursuant to the Rules and Regulations which are not so included or incorporated by reference.
(f) On the date of this Agreement and on the Closing Date, the Representative shall have
received a cold comfort letter from Reznick as of the date of the date of delivery and addressed
to the Underwriters and in form and substance satisfactory to the Representative and Underwriters
Counsel, confirming that they are independent certified public accountants with respect to the
Company within the meaning of the Securities Act and the Rules and Regulations, and stating, as of
the date of delivery (or, with respect to matters involving changes or developments since the
respective dates as of which specified financial information is given in the Prospectus, as of a
date not more than five (5) days prior to the date of such letter), the conclusions and findings of
such firm with respect to the financial information and other matters relating to the Registration
Statement covered by such letter.
(g) The Representative shall have received a lock-up agreement from each Lock-Up Party, duly
executed by the applicable Lock-Up Party, in each case substantially in the form attached as
Annex I
.
(h) The Representative shall have received the duly executed Warrant Agreement, in
substantially the form attached as
Annex II
.
(i) The
Common Shares shall have been approved for listing on the NYSE
Amex stock exchange.
(j) FINRA shall have confirmed that it has not raised any objection with respect to the
fairness and reasonableness of the underwriting terms and arrangements.
(k) No action shall have been taken and no statute, rule, regulation or order shall have been
enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority
that would, as of the Closing Date, prevent the issuance or sale of the Securities; and no
injunction or order of any federal, state or foreign court shall have been issued that would, as of
the Closing Date, prevent the issuance or sale of the Securities.
If any of the conditions specified in this Section 7 shall not have been fulfilled when and as
required by this Agreement, or if any of the certificates, opinions, written statements or letters
furnished to the Representative or to Underwriters Counsel pursuant to this Section 7 shall not be
reasonably satisfactory in form and substance to the Representative and to Underwriters Counsel,
all obligations of the Underwriters hereunder may be cancelled by the Representative at, or at any
time prior to, the consummation of the Closing. Notice of such cancellation shall be given to the
Company in writing, or by telephone. Any such telephone notice shall be confirmed promptly
thereafter in writing.
8.
Indemnification
.
-30-
Maxim Group LLC
May 17, 2010
Page 31 of 44
(a) (a) The Company agrees to indemnify and hold harmless the Underwriters and each Person, if
any, who controls each Underwriter within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act, against any losses, claims, damages or liabilities to which such
party may become subject, under the Securities Act or otherwise (including in settlement of any
litigation if such settlement is effected with the written consent of the Company), insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based
upon (i) an untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement, including the information deemed to be a part of the Registration Statement
at the time of effectiveness and at any subsequent time pursuant to Rules 430A and 430B of the
Rules and Regulations, the General Disclosure Package, the Prospectus, or any amendment or
supplement thereto (including any documents filed under the Exchange Act and deemed to be
incorporated by reference into the Prospectus), any Issuer Free Writing Prospectus or in any
materials or information provided to investors by, or with the approval of, the Company in
connection with the marketing of the offering of the Units (
Marketing Materials
), including any
roadshow or investor presentations made to investors by the Company (whether in person or
electronically) or arise out of or are based upon the omission or alleged omission to state therein
a material fact required to be stated therein or necessary to make the statements therein not
misleading, and will reimburse such indemnified party for any legal or other expenses reasonably
incurred by it in connection with investigating or defending against such loss, claim, damage,
liability or action; or (ii) in whole or in part upon any inaccuracy in the representations and
warranties of the Company contained herein; or (iii) in whole or in part upon any failure of the
Company to perform its obligations hereunder or under law; provided, however, that the Company
shall not be liable in any such case to the extent that any such loss, claim, damage, liability or
action arises out of or is based upon an untrue statement or alleged untrue statement or omission
or alleged omission made in the Registration Statement, any Preliminary Prospectus, the General
Disclosure Package, the Prospectus, or any such amendment or supplement, any Issuer Free Writing
Prospectus or in any Marketing Materials, in reliance upon and in conformity with the Underwriters
Information.
(b) Each Underwriter, severally and not jointly, shall indemnify and hold harmless the
Company, each of the directors of the Company, each of the officers of the Company who shall have
signed the Registration Statement, and each other Person, if any, who controls the Company within
the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any
losses, liabilities, claims, damages and expenses whatsoever as incurred (including but not limited
to attorneys fees and any and all expenses whatsoever incurred in investigating, preparing or
defending against any litigation, commenced or threatened, or any claim whatsoever, and any and all
amounts paid in settlement of any claim or litigation), joint or several, to which they or any of
them may become subject under the Securities Act, the Exchange Act or otherwise, insofar as such
losses, liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or
are based upon any untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement, as originally filed or any amendment thereof, or any related Preliminary
Prospectus or the Prospectus, or in any amendment thereof or supplement thereto, or arise out of or
are based upon the omission or
-31-
Maxim Group LLC
May 17, 2010
Page 32 of 44
alleged omission to state therein a material fact required to be stated therein or necessary
to make the statements therein not misleading, in each case to the extent, but only to the extent,
that any such loss, liability, claim, damage or expense arises out of or is based upon any such
untrue statement or alleged untrue statement or omission or alleged omission made therein in
reliance upon and in conformity with the Underwriters Information;
provided, however,
that in no
case shall any Underwriter be liable or responsible for any amount in excess of the underwriting
discount applicable to the Securities to be purchased by such Underwriter hereunder. The parties
agree that such information provided by or on behalf of any Underwriter through the Representative
consists solely of the material referred to in the last sentence of Section 1(b) hereof.
(c) Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice
of any claims or the commencement of any action, such indemnified party shall, if a claim in
respect thereof is to be made against the indemnifying party under such subsection, notify each
party against whom indemnification is to be sought in writing of the claim or the commencement
thereof (but the failure so to notify an indemnifying party shall not relieve the indemnifying
party from any liability which it may have under this Section 8 to the extent that it is not
materially prejudiced as a result thereof and in any event shall not relieve it from any liability
that such indemnifying party may have otherwise than on account of the indemnity agreement
hereunder). In case any such claim or action is brought against any indemnified party, and it
notifies an indemnifying party of the commencement thereof, the indemnifying party will be entitled
to participate, at its own expense in the defense of such action, and to the extent it may elect by
written notice delivered to the indemnified party promptly after receiving the aforesaid notice
from such indemnified party, to assume the defense thereof with counsel satisfactory to such
indemnified party; provided however, that counsel to the indemnifying party shall not (except with
the written consent of the indemnified party) also be counsel to the indemnified party.
Notwithstanding the foregoing, the indemnified party or parties shall have the right to employ its
or their own counsel in any such case, but the fees and expenses of such counsel shall be at the
expense of such indemnified party or parties unless (i) the employment of such counsel shall have
been authorized in writing by one of the indemnifying parties in connection with the defense of
such action, (ii) the indemnifying parties shall not have employed counsel to have charge of the
defense of such action within a reasonable time after notice of commencement of the action, (iii)
the indemnifying party does not diligently defend the action after assumption of the defense, or
(iv) such indemnified party or parties shall have reasonably concluded that there may be defenses
available to it or them which are different from or additional to those available to one or all of
the indemnifying parties (in which case the indemnifying parties shall not have the right to direct
the defense of such action on behalf of the indemnified party or parties), in any of which events
such fees and expenses shall be borne by the indemnifying parties. No indemnifying party shall,
without the prior written consent of the indemnified parties, effect any settlement or compromise
of, or consent to the entry of judgment with respect to, any pending or threatened claim,
investigation, action or proceeding in respect of which indemnity or contribution may be or could
have been sought by an indemnified party under this Section 8 or Section 9 hereof (whether or not
the indemnified party is an actual or potential party thereto), unless (x) such settlement,
compromise or judgment (i) includes an
-32-
Maxim Group LLC
May 17, 2010
Page 33 of 44
unconditional release of the indemnified party from all liability arising out of such claim,
investigation, action or proceeding and (ii) does not include a statement as to or an admission of
fault, culpability or any failure to act, by or on behalf of the indemnified party, and (y) the
indemnifying party confirms in writing its indemnification obligations hereunder with respect to
such settlement, compromise or judgment.
9.
Contribution
. To provide for contribution in circumstances in which the
indemnification provided for in Section 8 hereof is for any reason held to be unavailable from any
indemnifying party or is insufficient to hold harmless a party indemnified thereunder, the Company
and the Underwriters shall contribute to the aggregate losses, claims, damages, liabilities and
expenses of the nature contemplated by such indemnification provision (including any investigation,
legal and other expenses incurred in connection with, and any amount paid in settlement of, any
action, suit or proceeding or any claims asserted, but after deducting in the case of losses,
claims, damages, liabilities and expenses suffered by the Company, any contribution received by the
Company from Persons, other than the Underwriters, who may also be liable for contribution,
including Persons who control the Company within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act, officers of the Company who signed the Registration Statement and
directors of the Company) as incurred to which the Company and one or more of the Underwriters may
be subject, in such proportions as is appropriate to reflect the relative benefits received by the
Company and the Underwriters from the Offering or, if such allocation is not permitted by
applicable law, in such proportions as are appropriate to reflect not only the relative benefits
referred to above but also the relative fault of the Company and the Underwriters in connection
with the statements or omissions which resulted in such losses, claims, damages, liabilities or
expenses, as well as any other relevant equitable considerations. The relative benefits received
by the Company and the Underwriters shall be deemed to be in the same proportion as (x) the total
proceeds from the Offering (net of underwriting discounts and commissions but before deducting
expenses) received by the Company bears to (y) the underwriting discount or commissions received by
the Underwriters, in each case as set forth in the table on the cover page of the Prospectus. The
relative fault of each of the Company and of the Underwriters shall be determined by reference to,
among other things, whether the untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information supplied by the
Company or the Underwriters and the parties relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. The Company and the Underwriters
agree that it would not be just and equitable if contribution pursuant to this Section 9 were
determined by pro rata allocation (even if the Underwriters were treated as one entity for such
purpose) or by any other method of allocation which does not take account of the equitable
considerations referred to above in this Section. The aggregate amount of losses, liabilities,
claims, damages and expenses incurred by an indemnified party and referred to above in this Section
9 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified
party in investigating, preparing or defending against any litigation, or any investigation or
proceeding by any judicial, regulatory or other legal or governmental agency or body, commenced or
threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or
omission or alleged omission. Notwithstanding the provisions of this Section 9: (i) no
-33-
Maxim Group LLC
May 17, 2010
Page 34 of 44
Underwriter shall be required to contribute any amount in excess of the amount by which the
discounts and commissions applicable to the Shares underwritten by it and distributed to the public
exceeds the amount of any damages which such Underwriter has otherwise been required to pay by
reason of such untrue or alleged untrue statement or omission or alleged omission and (ii) no
Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any Person who was not guilty of such
fraudulent misrepresentation. For purposes of this Section 9, each Person, if any, who controls an
Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act shall have the same rights to contribution as such Underwriter, and each Person, if any, who
controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act, each officer of the Company who shall have signed the Registration Statement and each
director of the Company shall have the same rights to contribution as the Company, subject in each
case to clauses (i) and (ii) of the immediately preceding sentence. Any party entitled to
contribution will, promptly after receipt of notice of commencement of any action, suit or
proceeding against such party in respect of which a claim for contribution may be made against
another party or parties, notify each party or parties from whom contribution may be sought, but
the omission to so notify such party or parties shall not relieve the party or parties from whom
contribution may be sought from any obligation it or they may have under this Section 9 or
otherwise. The obligations of the Underwriters to contribute pursuant to this Section 9 are
several in proportion to the respective number of Shares to be purchased by each of the
Underwriters hereunder and not joint.
10.
Underwriter Default
.
(a) If any Underwriter or Underwriters shall default in its or their obligation to purchase
Firm Units hereunder, and if the Firm Units with respect to which such default relates (the
Default Units
) do not (after giving effect to arrangements, if any, made by the Representative
pursuant to subsection (b) below) exceed in the aggregate ten percent (10%) of the number of Firm
Units, each non-defaulting Underwriter, acting severally and not jointly, agrees to purchase from
the Company that number of Default Units that bears the same proportion of the total number of
Default Units then being purchased as the number of Firm Units set forth opposite the name of such
Underwriter on
Schedule A
hereto bears to the aggregate number of Firm Units set forth
opposite the names of the non-defaulting Underwriters, subject, however, to such adjustments to
eliminate fractional shares as the Representative in its sole discretion shall make.
(b) In the event that the aggregate number of Default Units exceeds ten percent (10%) of the
number of Firm Units, the Representative may in their discretion arrange for themselves or for
another party or parties (including any non-defaulting Underwriter or Underwriters who so agree) to
purchase the Default Units on the terms contained herein. In the event that within five (5)
calendar days after such a default the Representative do not arrange for the purchase of the
Default Units as provided in this Section 10, this Agreement shall thereupon terminate, without
liability on the part of the Company with respect thereto (except in each case as provided in
Sections 5, 7, 8, 10 and 12(d)) or the Underwriters, but nothing in this Agreement
-34-
Maxim Group LLC
May 17, 2010
Page 35 of 44
shall relieve a defaulting Underwriter or Underwriters of its or their liability, if any, to
the other Underwriters and the Company for damages occasioned by its or their default hereunder.
(c) In the event that any Default Units are to be purchased by the non-defaulting
Underwriters, or are to be purchased by another party or parties as aforesaid, the Representative
or the Company shall have the right to postpone the Closing Date for a period, not exceeding five
(5) Business Days, to effect whatever changes may thereby be made necessary in the Registration
Statement or the Prospectus or in any other documents and arrangements, and the Company agrees to
file promptly any amendment or supplement to the Registration Statement or the Prospectus which, in
the reasonable opinion of Underwriters Counsel, may thereby be made necessary or advisable. The
term Underwriter as used in this Agreement shall include any party substituted under this Section
10 with like effect as if it had originally been a party to this Agreement with respect to such
Firm Units.
11.
Survival of Representations and Agreements
. All representations and warranties,
covenants and agreements of the Company and the Underwriters contained in this Agreement or in
certificates of officers of the Company submitted pursuant hereto, including the agreements
contained in Section 6, the indemnity agreements contained in Section 8 and the contribution
agreements contained in Section 9 hereof, shall remain operative and in full force and effect
regardless of any investigation made by or on behalf of any Underwriter or any controlling Person
thereof or by or on behalf of the Company, any of its officers and directors or any controlling
Person thereof, and shall survive delivery of and payment for the Units to and by the Underwriters.
The representations contained in Section 1 and 2 hereof and the covenants and agreements contained
in Sections 5, 6, 8, 9, this Section 11 and Sections 15 and 16 hereof shall survive any termination
of this Agreement, including termination pursuant to Section 10 or 12 hereof.
12.
Effective Date of Agreement; Termination
.
(a) This Agreement shall become effective upon the later of: (i) receipt by the Representative
and the Company of notification of the effectiveness of the Registration Statement or (ii) the
execution of this Agreement. Notwithstanding any termination of this Agreement, the provisions of
this Section 12 and of Sections 1, 5, 7, 8 and 12 through 17, inclusive, shall remain in full force
and effect at all times after the execution hereof.
(b) The Representative shall have the right to terminate this Agreement at any time prior to
the consummation of the Closing if: (i) any domestic or international event or act or occurrence
has materially disrupted, or in the opinion of the Representative will in the immediate future
materially disrupt, the market for the Companys securities or securities in general; or (ii)
trading on the New York Stock Exchange, the NASDAQ or the NYSE Amex shall have been suspended or been
made subject to material limitations, or minimum or maximum prices for trading shall have been
fixed, or maximum ranges for prices for securities shall have been required, on the New York Stock
Exchange, the Nasdaq Stock Market or the NYSE Amex or by order of the Commission or any other
governmental authority having jurisdiction; or (iii) a
-35-
Maxim Group LLC
May 17, 2010
Page 36 of 44
banking moratorium has been declared by any state or federal authority or if any material
disruption in commercial banking or securities settlement or clearance services shall have
occurred; (iv) any downgrading shall have occurred in the Companys corporate credit rating or the
rating accorded the Companys debt securities or trust preferred stock by any nationally
recognized statistical rating organization (as defined for purposes of Rule 436(g) under the
Securities Act) or if any such organization shall have been publicly announced that it has under
surveillance or review, with possible negative implications, its rating of any of the Companys
debt securities; or (v) (A) there shall have occurred any outbreak or escalation of hostilities or
acts of terrorism involving the United States or there is a declaration of a national emergency or
war by the United States or (B) there shall have been any other calamity or crisis or any change in
political, financial or economic conditions if the effect of any such event in (A) or (B), in the
judgment of the Representative, is so material and adverse that such event makes it impracticable
or inadvisable to proceed with the offering, sale and delivery of the Firm Units on the terms and
in the manner contemplated by the Prospectus.
(c) Any notice of termination pursuant to this Section 12 shall be in writing.
(d) If this Agreement shall be terminated pursuant to any of the provisions hereof (other than
pursuant to Section 10(b) hereof), or if the sale of the Units provided for herein is not
consummated because any condition to the obligations of the Underwriters set forth herein is not
satisfied or because of any refusal, inability or failure on the part of the Company to perform any
agreement herein or comply with any provision hereof, the Company will, subject to demand by the
Representative, reimburse the Underwriters for only those out-of-pocket expenses (including the
fees and expenses of their counsel), actually incurred by the Underwriters in connection herewith.
13.
Notices
. All communications hereunder, except as may be otherwise specifically
provided herein, shall be in writing, and:
(a) if sent to the Representative or any Underwriter, shall be mailed, delivered, or faxed and
confirmed in writing, to Maxim Group LLC, 405 Lexington Avenue, New York, New York 10174,
Attention: Clifford A. Teller, Director of Investment Banking, with a copy to Underwriters
Counsel at Lowenstein Sandler PC, 65 Livingston Avenue, Roseland, New Jersey, Attention: Steven M.
Skolnick, Esq.; and
(b) if sent to the Company, shall be mailed, delivered, or faxed and confirmed in writing to
the Company and its counsel at the addresses set forth in the Registration Statement.
provided, however,
that any notice to an Underwriter pursuant to Section 8 shall be delivered or
sent by mail or facsimile transmission to such Underwriter at its address set forth in its
acceptance notice to the Representative, which address will be supplied to any other party hereto
by the Representative upon request. Any such notices and other communications shall take effect at
the time of receipt thereof.
-36-
Maxim Group LLC
May 17, 2010
Page 37 of 44
14.
Parties; Limitation of Relationship
. This Agreement shall inure solely to the
benefit of, and shall be binding upon, the Underwriters, the Company and the controlling Persons,
directors, officers, employees and agents referred to in Sections 7 and 8 hereof, and their
respective successors and assigns, and no other Person shall have or be construed to have any legal
or equitable right, remedy or claim under or in respect of or by virtue of this Agreement or any
provision herein contained. This Agreement and all conditions and provisions hereof are intended
to be for the sole and exclusive benefit of the parties hereto and said controlling Persons and
their respective successors, officers, directors, heirs and legal Representative, and it is not for
the benefit of any other Person. The term successors and assigns shall not include a purchaser,
in its capacity as such, of Units from any of the Underwriters.
15.
Governing Law
. This Agreement shall be deemed to have been executed and delivered
in New York and both this Agreement and the transactions contemplated hereby shall be governed as
to validity, interpretation, construction, effect, and in all other respects by the laws of the
State of New York, without regard to the conflicts of laws principals thereof (other than Section
5-1401 of The New York General Obligations Law). Each of the Underwriters and the Company: (a)
agrees that any legal suit, action or proceeding arising out of or relating to this Agreement or
the transactions contemplated hereby shall be instituted exclusively in the Supreme Court of the
State of New York, New York County, or in the United States District Court for the Southern
District of New York, (b) waives any objection which it may have or hereafter to the venue of any
such suit, action or proceeding, and (c) irrevocably consents to the jurisdiction of Supreme Court
of the State of New York, New York County, or in the United States District Court for the Southern
District of New York in any such suit, action or proceeding. Each of the Underwriters and the
Company further agrees to accept and acknowledge service of any and all process which may be served
in any such suit, action or proceeding in the Supreme Court of the State of New York, New York
County, or in the United States District Court for the Southern District of New York and agrees
that service of process upon the Company mailed by certified mail to the Companys address or
delivered by Federal Express via overnight delivery shall be deemed in every respect effective
service of process upon the Company, in any such suit, action or proceeding, and service of process
upon the Underwriters mailed by certified mail to the Underwriters address or delivered by Federal
Express via overnight delivery shall be deemed in every respect effective service process upon the
Underwriter, in any such suit, action or proceeding. THE COMPANY (ON BEHALF OF ITSELF AND, TO THE
FULLEST EXTENT PERMITTED BY LAW, ON BEHALF OF ITS RESPECTIVE EQUITY HOLDERS AND CREDITORS) HEREBY
WAIVE ANY RIGHT THEY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY CLAIM BASED UPON, ARISING OUT OF
OR IN CONNECTION WITH THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, THE
REGISTRATION STATEMENT AND THE PROSPECTUS.
16.
Entire Agreement
. This Agreement, together with the schedule and exhibits
attached hereto and as the same may be amended from time to time in accordance with the terms
hereof, contains the entire agreement among the parties hereto relating to the subject matter
-37-
Maxim Group LLC
May 17, 2010
Page 38 of 44
hereof and there are no other or further agreements outstanding not specifically mentioned
herein.
17.
Severability
. If any term or provision of this Agreement or the performance
thereof shall be invalid or unenforceable to any extent, such invalidity or unenforceability shall
not affect or render invalid or unenforceable any other provision of this Agreement and this
Agreement shall be valid and enforced to the fullest extent permitted by law.
18.
Amendment
. This Agreement may only be amended by a written instrument executed by
each of the parties hereto.
19.
Waiver, etc.
The failure of any of the parties hereto to at any time enforce any
of the provisions of this Agreement shall not be deemed or construed to be a waiver of any such
provision, nor to in any way effect the validity of this Agreement or any provision hereof or the
right of any of the parties hereto to thereafter enforce each and every provision of this
Agreement. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of
this Agreement shall be effective unless set forth in a written instrument executed by the party or
parties against whom or which enforcement of such waiver is sought; no waiver of any such breach,
non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or
subsequent breach, non-compliance or non-fulfillment.
20.
No Fiduciary Relationship
. The Company hereby acknowledges that the Underwriters
are acting solely as underwriters in connection with the offering of the Companys securities. The
Company further acknowledge that the Underwriters are acting pursuant to a contractual relationship
created solely by this Agreement entered into on an arms length basis and in no event do the
parties intend that the Underwriters act or be responsible as a fiduciary to the Company, its
management, shareholders, creditors or any other person in connection with any activity that the
Underwriters may undertake or have undertaken in furtherance of the offering of the Companys
securities, either before or after the date hereof. The Underwriters hereby expressly disclaim any
fiduciary or similar obligations to the Company, either in connection with the transactions
contemplated by this Agreement or any matters leading up to such transactions, and the Company
hereby confirms its understanding and agreement to that effect. The Company hereby further confirms
its understand that no Underwriter has assumed an advisory or fiduciary responsibility in favor of
the Company with respect to the Offering contemplated hereby or the process leading thereto,
including any negotiation related to the pricing of the Units; the Company has consulted its own
legal and financial advisors to the extent it has deemed appropriate in connection with this
Agreement and the Offering. The Company and the Underwriters agree that they are each responsible
for making their own independent judgments with respect to any such transactions, and that any
opinions or views expressed by the Underwriters to the Company regarding such transactions,
including but not limited to any opinions or views with respect to the price or market for the
Companys securities, do not constitute advice or recommendations to the Company. The Company
hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may
have against the Underwriters with respect to any breach or alleged breach of any fiduciary or
similar duty to
-38-
Maxim Group LLC
May 17, 2010
Page 39 of 44
the Company in connection with the transactions contemplated by this Agreement or any matters
leading up to such transactions.
21.
Counterparts
. This Agreement may be executed in any number of counterparts, each
of which shall be deemed to be an original, but all such counterparts shall together constitute one
and the same instrument. Delivery of a signed counterpart of this Agreement by facsimile
transmission shall constitute valid and sufficient delivery thereof.
22.
Headings
. The headings herein are inserted for convenience of reference only and
are not intended to be part of, or to affect the meaning or interpretation of, this Agreement.
23.
Time is of the Essence
. Time shall be of the essence of this Agreement. As used
herein, the term Business Day shall mean any day other than a Saturday, Sunday or any day on
which the major stock exchanges in New York, New York are not open for business.
[Signature Pages Follow]
-39-
Maxim Group LLC
May 17, 2010
Page 40 of 44
If the foregoing correctly sets forth your understanding, please so indicate in the space
provided below for that purpose, whereupon this letter shall constitute a binding agreement among
us.
|
|
|
|
|
|
Very truly yours,
REGENERX BIOPHARMACEUTICALS, INC.
|
|
|
By:
|
/s/ J. J. Finkelstein
|
|
|
|
Name:
|
J. J. Finkelstein
|
|
|
|
Title:
|
President and Chief Executive Officer
|
|
|
-40-
Maxim Group LLC
May 17, 2010
Page 41 of 44
Accepted by the Representative, acting for themselves and as
Representative of the Underwriters named on
Schedule A
attached hereto,
as of the date first written above:
|
|
|
|
|
MAXIM GROUP LLC
|
|
|
|
|
|
|
|
By:
|
|
/s/ Clifford A. Teller
|
|
|
|
|
Name: Clifford A. Teller
|
|
|
|
|
Title: Executive Managing Director Investment Banking
|
|
|
-41-
SCHEDULE A
Underwriters
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Firm
|
|
|
|
|
|
|
Shares to be
|
|
|
|
|
|
|
Purchased from the
|
|
|
|
Over-Allotment
|
Underwriter
|
|
Company
|
|
|
|
Option Shares
|
Maxim Group LLC
|
|
|
9,200,000
|
|
|
|
|
|
|
|
1,380,000
|
|
Chardan Capital Markets, LLC
|
|
|
1,725,000
|
|
|
|
|
|
|
|
258,750
|
|
Boenning & Scattergood, Inc.
|
|
|
575,000
|
|
|
|
|
|
|
|
86,250
|
|
TOTAL
|
|
|
11,500,000
|
|
|
|
|
|
|
|
1,725,000
|
|
SCHEDULE B
Lock-Up Parties
J.J. Finkelstein
C. Neil Lyons
David R. Crockford
Allan L. Goldstein
Richard J. Hindin
Joseph C. McNay
Mauro Bove
L. Thompson Bowles
Sigma - Tau Finanziaria S.p.A.
Defiante Farmaceutica S.A.
Chaumiere - Consultadoria & Services SDC Unipessoal LDA
Inverlochy - Consultadoria & Services (S. U.) LDA
SCHEDULE C
Issuer-Represented General Free Writing Prospectus
None
ANNEX I
Form Lock-Up Agreement
ANNEX II
Form of Warrant Agreement
Exhibit 4.1
WARRANT AGREEMENT
This
Warrant Agreement made as of May 21, 2010, is between RegeneRx Biopharmaceuticals, Inc.,
a Delaware corporation, with offices at 15245 Shady Grove Road, Suite 470, Rockville, MD 20850 (the
Company
), and American Stock Transfer & Trust Company, LLC, with offices at 6201 15th Avenue,
Brooklyn, NY (the
Warrant Agent
).
WHEREAS, the Company is engaged in a public offering of units, each unit comprised of one
share of Common Stock (as defined below) and 0.4 Warrants (as defined below) and, in connection
therewith, has determined to issue and deliver up to 13,225,000 warrants (the
Warrants
) to the
investors in the public offering, each Warrant evidencing the right of the holder thereof to
purchase one share of the Companys common stock, par value $0.001 per share (the
Common Stock
),
for $0.56, subject to adjustment as described herein;
WHEREAS, the Company has filed with the Securities and Exchange Commission a registration
statement on Form S-3 (File No. 333-166146) (the
Registration Statement
), for the registration
under the Securities Act of 1933, as amended (the
Act
), of, among other securities, the Warrants
and the Common Stock issuable upon exercise of the Warrants;
WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the
Warrant Agent is willing to so act, in connection with the issuance, registration, transfer,
exchange, redemption and exercise of the Warrants;
WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms
upon which they shall be issued and exercised, and the respective rights, limitation of rights and
immunities of the Company, the Warrant Agent and the holders of the Warrants; and
WHEREAS, all acts and things have been done and performed which are necessary to make the
Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant
Agent, as provided herein, the legally valid and binding obligations of the Company, and to
authorize the execution and delivery of this Warrant Agreement.
NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto
agree as follows:
1.
Appointment of Warrant Agent
. The Company hereby appoints the Warrant
Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such
appointment and agrees to perform the same in accordance with the terms and conditions set forth in
this Warrant Agreement.
2.
Warrants
.
2.1
Form of Warrant
. Each Warrant shall be (a) issued in registered form
only, (b) in substantially the form of
Exhibit A
attached hereto, the provisions of which
are incorporated herein, and (c) signed by, or bear the facsimile signature of, (i) the Chairman of
the Board, the Chief Executive Officer or the President, and (ii) the Treasurer, Secretary or
Assistant
- 1 -
Secretary of the Company. In the event a person whose facsimile signature has been placed upon
any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant
before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased
to be such at the date of issuance.
2.2
Effect of Countersignature
. Unless and until countersigned by the
Warrant Agent pursuant to this Warrant Agreement, a Warrant shall be invalid and of no effect and
may not be exercised by the holder thereof. Warrant certificates shall be dated the date of
countersignature by the Warrant Agent.
2.3
Registration
.
2.3.1
Warrant Register
. The Warrant Agent shall maintain books (
Warrant
Register
), for the registration of the original issuance and transfers of the Warrants. Upon the
initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the
names of the respective holders thereof in such denominations and otherwise in accordance with
instructions delivered to the Warrant Agent by the Company.
2.3.2
Registered Holder
. Prior to due presentment for registration of
transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose
name such Warrant shall be registered upon the Warrant Register (
Registered Holder
), as the
absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any
notation of ownership or other writing on the warrant certificate made by anyone other than the
Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes,
and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.
3.
Terms and Exercise of Warrants
.
3.1
Warrant Price
. Each whole Warrant shall, when countersigned by the
Warrant Agent, entitle the Registered Holder thereof, subject to the provisions of such Warrant and
of this Warrant Agreement, to purchase from the Company one share of Common Stock, at the price of
$0.56 per whole share, subject to the adjustments provided in Section 4 hereof and in the last
sentence of this Section 3.1. The term
Warrant Price
as used in this Warrant Agreement refers to
the price per share at which Common Stock may be purchased at the time a Warrant is exercised. The
Company, in its sole discretion, may lower the Warrant Price at any time prior to the Expiration
Date (as defined below); provided, that any such reduction shall be identical in percentage terms
among all of the Warrants; and provided, further, that in no event shall the Warrant Price be
reduced below the par value of one share of Common Stock.
3.2
Duration of Warrants
. The Warrants will be exercisable until 5:00 p.m.,
New York City time, on the Expiration Date. For purposes of this Warrant Agreement, the
Expiration Date
shall mean the earlier to occur of
(i) May 21, 2015, or (ii) the date fixed for
redemption of the Warrants as provided in Section 6 of this Warrant Agreement. Except with respect
to the right to receive the Redemption Price (as set forth in Section 6 hereunder), each Warrant
not exercised on or before the Expiration Date shall become void, and all rights
- 2 -
thereunder and all rights in respect thereof under this Warrant Agreement shall cease at the
close of business on the Expiration Date. The Company may extend the duration of the Warrants by
delaying the Expiration Date; provided, however, that the Company will provide notice of any such
extension to each registered holder of the Warrants, at the last address for such holder as set
forth in the Warrant Register, not less than twenty (20) days prior to the Expiration Date then in
effect.
3.3
Exercise of Warrants
.
3.3.1
Payment
. Subject to the provisions of the Warrant and this Warrant
Agreement, a Warrant, when countersigned by the Warrant Agent, may be exercised by the Registered
Holder thereof by surrendering it, at the office of the Warrant Agent, or at the office of its
successor as Warrant Agent, with the subscription form, as set forth in the Warrant, duly executed,
and by paying in full, in lawful money of the United States, by certified check made payable to the
Company or by wire transfer of immediately available funds to an account designated by the Company
(or as otherwise agreed to by the Company), the Warrant Price for each full share of Common Stock
as to which the Warrant is exercised and any and all applicable taxes due in connection with the
exercise of the Warrant, the exchange of the Warrant for the Common Stock, and the issuance of the
Common Stock. In no event shall the Registered Holder of any Warrant be entitled to net cash
settle the Warrant.
3.3.2
Issuance of Certificates
. As soon as practicable after the exercise of
any Warrant and the clearance of the funds in payment of the Warrant Price for each full share of
Common Stock as to which the Warrant is exercised, the Company shall issue to the Registered Holder
of such Warrant a certificate or certificates representing the number of full shares of Common
Stock to which he, she or it is entitled, registered in such name or names as may be directed by
him, her or it, and, if such Warrant shall not have been exercised or surrendered in full, a new
countersigned Warrant for the number of shares as to which such Warrant shall not have been
exercised or surrendered. Subject to Section 7.4 and notwithstanding the foregoing, the Company
shall not be obligated to deliver any securities pursuant to the exercise of a Warrant unless (a) a
registration statement under the Act with respect to the Common Stock issuable upon exercise of
such Warrants is effective and a current prospectus relating to the shares of Common Stock issuable
upon exercise of the Warrants is available for delivery to the Warrant holders or (b) in the
opinion of counsel to the Company, the exercise of the Warrants is exempt from the registration
requirements of the Act and such securities are qualified for sale or exempt from qualification
under applicable securities laws of the states or other jurisdictions in which the Registered
Holder resides. Warrants may not be exercised by, or securities issued to, any Registered Holder in
any state in which such exercise or issuance would be unlawful. In the event a registration
statement under the Act with respect to the Common Stock underlying the Warrants is not effective
or a prospectus is not available, or because such exercise would be unlawful with respect to a
Registered Holder in any state, the Registered Holder shall not be entitled to exercise such
Warrants and such Warrants may have no value and expire worthless. In no event will the Company be
obligated to pay such Registered Holder any cash consideration upon exercise (except pursuant to
Section 4.5).
- 3 -
3.3.3
Valid Issuance
. All shares of Common Stock issued upon the proper
exercise or surrender of a Warrant in conformity with this Warrant Agreement shall be validly
issued, fully paid and nonassessable.
3.3.4
Date of Issuance
. Each person or entity in whose name any such
certificate for shares of Common Stock is issued shall, for all purposes, be deemed to have become
the holder of record of such shares on the date on which the Warrant was surrendered and payment of
the Warrant Price for each full share of Common Stock as to which the Warrant is exercised was
made, irrespective of the date of delivery of such certificate, except that, if the date of such
surrender and payment is a date when the stock transfer books of the Company are closed, such
person shall be deemed to have become the holder of such shares at the close of business on the
next succeeding date on which the stock transfer books are open.
3.4
Disposition of Proceeds on Exercise of Warrants
. The Warrant Agent
shall promptly forward to the Company all monies received by the Warrant Agent for the purchase of
shares of Common Stock through the exercise of Warrants.
4.
Adjustments
.
4.1
Stock Dividends Split-Ups
. If, after the date hereof, and subject to
the provisions of Section 4.6 below, the number of outstanding shares of Common Stock is increased
by a stock dividend payable in shares of Common Stock, or by a split-up of shares of Common Stock,
or other similar event, then, on the effective date of such stock dividend, split-up or similar
event, the number of shares of Common Stock issuable on exercise of each Warrant shall be increased
in proportion to such increase in outstanding shares of Common Stock.
4.2
Aggregation of Shares
. If, after the date hereof, and subject to the
provisions of Section 4.6, the number of outstanding shares of Common Stock is decreased by a
consolidation, combination, reverse stock split or reclassification of shares of Common Stock or
other similar event, then, on the effective date of such consolidation, combination, reverse stock
split, reclassification or similar event, the number of shares of Common Stock issuable on exercise
of each Warrant shall be decreased in proportion to such decrease in outstanding shares of Common
Stock.
4.3
Adjustments in Warrant Price
. Whenever the number of shares of Common
Stock purchasable upon the exercise of the Warrants is adjusted, as provided in Sections 4.1 and
4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant
Price, immediately prior to such adjustment, by a fraction, (a) the numerator of which shall be the
number of shares of Common Stock purchasable upon the exercise of the Warrants immediately prior to
such adjustment, and (b) the denominator of which shall be the number of shares of Common Stock so
purchasable immediately thereafter. Notwithstanding the foregoing or anything to the contrary
herein, in no event shall the Warrant Price be reduced below the par value of one share of Common
Stock.
4.4
Extraordinary Dividends
. If the Company, at any time prior to the
Expiration Date, shall pay a dividend in cash, securities or other assets to the holders of Common
- 4 -
Stock (or other shares of the Companys capital stock into which the Warrants are
convertible), other than (i) as described in Sections 4.1, 4.2 or 4.5 or (ii) regular quarterly or
other periodic dividends (any such non-excluded event being referred to herein as an
Extraordinary
Dividend
), then the Warrant Price shall be decreased, effective immediately after the effective
date of such Extraordinary Dividend, by the amount of cash and/or the fair market value (as
determined by the Companys Board of Directors, in good faith) of any securities or other assets
paid on each share of Common Stock in respect of such Extraordinary Dividend.
4.5
Replacement of Securities upon Reorganization, etc.
In case of any
reclassification or reorganization of the outstanding shares of Common Stock (other than a change
covered by Sections 4.1 or 4.2 hereof or one that solely affects the par value of such shares of
Common Stock), or, in the case of any merger or consolidation of the Company with or into another
corporation (other than a consolidation or merger in which the Company is the continuing
corporation and that does not result in any reclassification or reorganization of the outstanding
shares of Common Stock), or, in the case of any sale or conveyance to another corporation or entity
of the assets or other property of the Company as an entirety or substantially as an entirety, in
connection with which the Company is dissolved, the Warrant holders shall thereafter have the right
to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants
and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and
receivable upon the exercise of the rights represented thereby, the kind and amount of shares of
stock or other securities or property (including cash) receivable upon such reclassification,
reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer,
that the Warrant holder would have received if such Warrant holder had exercised his, her or its
Warrant(s) immediately prior to such event; and if any reclassification also results in a change in
shares of Common Stock covered by Sections 4.1 or 4.2, then such adjustment shall be made pursuant
to Sections 4.1, 4.2, 4.3 and this Section 4.5. The provisions of this Section 4 shall similarly
apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other
transfers.
4.6
Notices of Changes in Warrant
. Upon every adjustment of the Warrant
Price or the number of shares issuable upon exercise of a Warrant, the Company shall give written
notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such
adjustment and the increase or decrease, if any, in the number of shares purchasable at such price
upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and
the facts upon which such calculation is based. Upon the occurrence of any event specified in
Sections 4.1, 4.2, 4.3, 4.4 or 4.5 the Company shall give written notice to each Warrant holder, at
the last address set forth for such holder in the Warrant Register, of the record date or the
effective date of the event. Failure to give such notice, or any defect therein, shall not affect
the legality or validity of such event.
4.7
No Fractional Shares
. Notwithstanding any provision contained in this
Warrant Agreement to the contrary, Warrants can only be exercised to the extent aggregated for
whole shares of Common Stock, and the Company shall not issue fractional shares upon exercise of
Warrants.
- 5 -
4.8
Form of Warrant
. The form of Warrant need not be changed because of any
adjustment pursuant to this Section 4, and Warrants issued after such adjustment may state the same
Warrant Price and the same number of shares as is stated in the Warrants initially issued pursuant
to this Warrant Agreement. However, the Company may, at any time, in its sole discretion, make any
change in the form of Warrant that the Company may deem appropriate and that does not affect the
substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange or
substitution for an outstanding Warrant or otherwise, may be in the form as so changed.
4.9
Notice of Certain Transactions
. In the event that the Company shall
propose to (a) offer the holders of its Common Stock rights to subscribe for or to purchase any
securities convertible into shares of Common Stock or shares of stock of any class or any other
securities, rights or options, (b) issue any rights, options or warrants entitling the holders of
Common Stock to subscribe for shares of Common Stock or (c) make a tender offer, redemption offer
or exchange offer with respect to the Common Stock, the Company shall send to the Warrant holders a
notice of such proposed action or offer. Such notice shall be mailed to the registered holders at
their addresses as they appear in the Warrant Register, which shall specify the record date for the
purposes of such offer or issuance of rights, or the date such issuance or event is to take place
and the last date for participation therein by the holders of Common Stock, if any such date has
been fixed, and shall briefly indicate the effect of such action on the Common Stock and on the
number and kind of any other shares of stock and on other property, if any, and the number of
shares of Common Stock and other property, if any, issuable upon exercise of each Warrant and the
Warrant Price after giving effect to any adjustment pursuant to this Article 4 which would be
required as a result of such action. Such notice shall be given as promptly as practicable after
the Board has determined to take any such action and (x) in the case of any action covered by
clause (a) or (b) above at least ten (10) days prior to the record date for determining the holders
of the Common Stock for purposes of such action or (y) in the case of any other such action at
least twenty (20) days prior to the date of the taking of such proposed action or the last date for
participation therein by the holders of Common Stock, whichever shall be the earlier.
4.10
Other Events
. If any event occurs as to which the foregoing provisions
of this Article 4 are not strictly applicable or, if strictly applicable, would not, in the good
faith judgment of the Board, fairly and adequately protect the purchase rights of the registered
holders of the Warrants in accordance with the essential intent and principles of such provisions,
then the Board shall make such adjustments in the application of such provisions, in accordance
with such essential intent and principles, as shall be reasonably necessary, in the good faith
opinion of the Board, to protect such purchase rights as aforesaid.
5.
Transfer and Exchange of Warrants
.
5.1
Registration of Transfer
. The Warrant Agent shall register the transfer,
from time to time, of any outstanding Warrant into the Warrant Register, upon surrender of such
Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by
appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal
aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the
- 6 -
Warrant Agent. The Warrants so cancelled shall be delivered by the Warrant Agent to the
Company from time to time upon the Companys request.
5.2
Procedure for Surrender of Warrants
. Warrants may be surrendered to the
Warrant Agent, together with a written request for exchange or transfer, and, thereupon, the
Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the
Registered Holder of the Warrants so surrendered, representing an equal aggregate number of
Warrants; provided, however, that, in the event a Warrant surrendered for transfer bears a
restrictive legend, the Warrant Agent shall not cancel such Warrant and shall issue new Warrants in
exchange therefor until the Warrant Agent has received an opinion of counsel for the Company
stating that such transfer may be made and indicating whether the new Warrants must also bear a
restrictive legend.
5.3
Fractional Warrants
. Following the initial issuance of the Warrants by
the Company, the Warrant Agent shall not be required to effect any registration of transfer or
exchange which will result in the issuance of a warrant certificate for a fraction of a warrant.
If the holder of any Warrant would be entitled, upon any such transfer or exchange, to receive a
fractional interest in a Warrant, the Warrant Agent shall, upon such transfer or exchange, round
down to a whole number of Warrants to be issued upon such transfer or exchange.
5.4
Service Charges
. No service charge shall be made for any exchange or
registration of transfer of Warrants.
5.5
Warrant Execution and Countersignature
. The Warrant Agent is hereby
authorized to countersign and to deliver, in accordance with the terms of this Warrant Agreement,
the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company,
whenever required by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed
on behalf of the Company for such purpose.
6.
Redemption
.
6.1
Redemption
. Subject to the penultimate and final sentences of this
Section 6.1, all, but not less than all, of the outstanding Warrants may be redeemed, at the option
of the Company, at any time after they become exercisable and prior to their expiration, at the
office of the Warrant Agent, upon the notice referred to in Section 6.2, in whole but not in part,
at the price of $0.01 per whole Warrant (
Redemption Price
), provided that the last sales price of
the Common Stock has been equal to or greater than $1.78 per share for any twenty (20) trading days
within a thirty (30) consecutive trading day period ending on the third business day prior to the
date on which notice of redemption is given. Notwithstanding anything to the contrary contained
herein, the Company shall not call the Warrants for redemption unless there is an effective
registration statement under the Act relating to the shares of Common Stock issuable upon exercise
of the Warrants current and available at the time of the notice required by Section 6.2 and at the
time of redemption.
6.2
Date Fixed for, and Notice of, Redemption
. In the event the Company
shall elect to redeem all of the Warrants, the Company shall fix a date for the redemption. Notice
- 7 -
of redemption shall be mailed by first class mail, postage prepaid, by the Company not less
than thirty (30) days prior to the date fixed for redemption to the Registered Holders of the
Warrants to be redeemed at their last addresses as they shall appear on the Warrant Register. Any
notice required to be given under this Warrant Agreement to the Registered Holder which is mailed
in the manner herein provided shall be conclusively presumed to have been duly given, whether or
not the Registered Holder received such notice.
6.3
Exercise After Notice of Redemption
. The Warrants may be exercised in
accordance with Section 3 of this Warrant Agreement at any time after notice of redemption shall
have been given by the Company pursuant to Section 6.2 hereof and prior to the time and date fixed
for redemption. On and after the redemption date, the record holder of the Warrants shall have no
further rights except to receive, upon surrender of the Warrants, the Redemption Price.
7.
Other Provisions Relating to Rights of Holders of Warrants
.
7.1
No Rights as Stockholder
. A Warrant does not entitle the Registered
Holder thereof to any of the rights of a stockholder of the Company, including, without limitation,
the right to receive dividends, or other distributions, exercise any preemptive rights to vote or
to consent or to receive notice as stockholders in respect of the meetings of stockholders or the
election of directors of the Company or any other matter.
7.2
Lost, Stolen Mutilated or Destroyed Warrants
. If any Warrant is lost,
stolen, mutilated or destroyed, the Company and the Warrant Agent may, on such terms as to
indemnity or otherwise as they may in their discretion impose (which terms shall, in the case of a
mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor
and date as the Warrant so lost, stolen, mutilated or destroyed. Any such new Warrant shall
constitute a substitute contractual obligation of the Company, whether or not the allegedly lost,
stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone.
7.3
Reservation of Common Stock
. The Company shall at all times reserve and
keep available a number of its authorized but unissued shares of Common Stock that will be
sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this
Warrant Agreement.
7.4
Registration of Common Stock
. The Company will use its best efforts to
maintain the effectiveness of the Registration Statement, including by the filing of any required
post-effective amendments to such Registration Statement, and ensure that a prospectus is available
for delivery to the Warrant holders until the expiration of the Warrants in accordance with the
provisions of this Warrant Agreement. The Warrants shall not be exercisable and the Company shall
not be obligated to issue Common Stock unless, at the time a holder seeks to exercise Warrants, a
prospectus related to the Common Stock issuable upon exercise of the Warrants is current and the
Common Stock has been registered or qualified or deemed to be exempt under the laws of the state of
residence of the holder of the Warrants. In addition, the Company agrees to use its best efforts
to register such securities under the blue sky laws of the states of residence of exercising
warrant holders, if permitted by the blue sky laws of such
- 8 -
jurisdictions, in the event that an exemption is not available; provided, however, that the
Company shall not be required to register or qualify in any particular jurisdiction in which the
Company would be required to qualify to do business or to execute a general consent to service of
process in effecting such registration or qualification. The provisions of this Section 7.4 may
not be modified, amended or deleted without the prior written consent of Maxim Group LLC.
8.
Concerning the Warrant Agent and Other Matters
.
8.1
Payment of Taxes
. The Company will, from time to time, promptly pay all
taxes and charges that may be imposed upon the Company or the Warrant Agent in respect of the
issuance or delivery of shares of Common Stock upon the exercise of Warrants, but the Company shall
not be obligated to pay any transfer taxes in respect of the Warrants or such shares.
8.2
Resignation, Consolidation, or Merger of Warrant Agent
.
8.2.1
Appointment of Successor Warrant Agent
. The Warrant Agent, or any
successor to it hereafter appointed, may resign its duties and be discharged from all further
duties and liabilities hereunder after giving sixty (60) days notice in writing to the Company. If
the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise,
the Company shall appoint, in writing, a successor Warrant Agent in place of the Warrant Agent. If
the Company shall fail to make such appointment within a period of thirty (30) days after it has
been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of
the Warrant (who shall, with such notice, submit his, her or its Warrant for inspection by the
Company), then the holder of any Warrant may apply to the Supreme Court of the State of New York
for the County of New York for the appointment of a successor Warrant Agent. Any successor Warrant
Agent, whether appointed by the Company or by such court, shall be a corporation organized and
existing under the laws of the State of New York, in good standing and have its principal office in
the Borough of Manhattan, City and State of New York, and be authorized under such laws to exercise
corporate trust powers and subject to supervision or examination by federal or state authorities.
After appointment, any successor Warrant Agent shall be vested with all the authority, powers,
rights, immunities, duties and obligations of its predecessor Warrant Agent with like effect as if
originally named as Warrant Agent hereunder, without any further act or deed; but, if for any
reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and
deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent
all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and, upon
request of any successor Warrant Agent, the Company shall make, execute, acknowledge, and deliver
any and all instruments in writing for more fully and effectually vesting in and confirming to such
successor Warrant Agent all such authority, powers, rights, immunities, duties and obligations.
8.2.2
Notice of Successor Warrant Agent
. In the event a successor Warrant
Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent
and the transfer agent for the Common Stock not later than the effective date of any such
appointment.
- 9 -
8.2.3
Merger or Consolidation of Warrant Agent
. Any corporation into which
the Warrant Agent may be merged or with which it may be consolidated or any corporation resulting
from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor
Warrant Agent under this Warrant Agreement without any further act on the part of the Company or
the Warrant Agent.
8.3
Fees and Expenses of Warrant Agent
.
8.3.1
Remuneration
. The Company agrees to pay the Warrant Agent reasonable
remuneration for its services as Warrant Agent hereunder as set forth on
Exhibit B
hereto
and will reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may
reasonably incur in the execution of its duties hereunder.
8.3.2
Further Assurances
. The Company agrees to perform, execute,
acknowledge and deliver, or cause to be performed, executed, acknowledged and delivered, all such
further and other acts, instruments and assurances as may reasonably be required by the Warrant
Agent for the carrying out or performing of the provisions of this Warrant Agreement.
8.4
Liability of Warrant Agent
.
8.4.1
Reliance on Company Statement
. Whenever, in the performance of its
duties under this Warrant Agreement, the Warrant Agent shall deem it necessary or desirable that
any fact or matter be proved or established by the Company prior to taking or suffering any action
hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically
prescribed) may be deemed to be conclusively proved and established by a statement signed by the
Chief Executive Officer, Chief Financial Officer or Chairman of the Board of the Company and
delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken
or suffered in good faith by it pursuant to the provisions of this Warrant Agreement.
8.4.2
Indemnity
. The Warrant Agent shall be liable hereunder only for its
own negligence, willful misconduct or bad faith. The Company agrees to indemnify the Warrant Agent
and save it harmless against any and all liabilities, including judgments, costs and reasonable
counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Warrant
Agreement, except as a result of the Warrant Agents negligence, willful misconduct or bad faith.
8.4.3
Exclusions
. The Warrant Agent shall have no responsibility with
respect to the validity of this Warrant Agreement or with respect to the validity or execution of
any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by
the Company of any covenant or condition contained in this Warrant Agreement or in any Warrant; nor
shall it be responsible to make any adjustments required under the provisions of Section 4 hereof
or responsible for the manner, method or amount of any such adjustment or the ascertaining of the
existence of facts that would require any such adjustment; nor shall it, by any act hereunder, be
deemed to make any representation or warranty as to the authorization or reservation of any shares
of Common Stock to be issued pursuant to this Warrant Agreement or
- 10 -
any Warrant or as to whether any shares of Common Stock will when issued be valid and fully
paid and nonassessable.
8.5
Acceptance of Agency
. The Warrant Agent hereby accepts the agency
established by this Warrant Agreement and agrees to perform the same upon the terms and conditions
herein set forth and, among other things, shall account promptly to the Company with respect to
Warrants exercised and concurrently account for, and pay to the Company, all moneys received by the
Warrant Agent for the purchase of shares of the Companys Common Stock through the exercise of
Warrants.
9.
Miscellaneous Provisions
.
9.1
Successors
. All the covenants and provisions of this Warrant Agreement
by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit of
their respective successors and assigns.
9.2
Notices
. Any notice, statement or demand authorized by this Warrant
Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the
Company shall be delivered by hand or sent by registered or certified mail or overnight courier
service, addressed (until another address is filed in writing by the Company with the Warrant
Agent) as follows:
RegeneRx Biopharmaceuticals, Inc.
15245 Shady Grove Road, Suite 470
Rockville, MD 20850
Attn: Chief Executive Officer
Any notice, statement or demand authorized by this Warrant Agreement to be given or made by the
holder of any Warrant or by the Company to or on the Warrant Agent shall be delivered by hand or
sent by registered or certified mail or overnight courier service, addressed (until another address
is filed in writing by the Warrant Agent with the Company), as follows:
American Stock Transfer & Trust Company, LLC
6201 15
th
Avenue
Brooklyn, NY 11219
Attn: Susan Silber
with a copy in each case to (which shall not constitute notice):
Cooley LLP
One Freedom Square
Reston Town Center
11951 Freedom Drive
Reston, VA 20190
Attn: Darren K. DeStefano, Esq.
- 11 -
Maxim Group LLC
405 Lexington Avenue
New York, NY 10174
Attn: David Strupp
Lowenstein Sandler PC
65 Livingston Avenue
Roseland, New Jersey 07068
Attn: Steven M. Skolnick, Esq.
Any notice, sent pursuant to this Warrant Agreement shall be effective, if delivered by hand, upon
receipt thereof by the party to whom it is addressed, if sent by overnight courier, on the next
business day of the delivery to the courier, and if sent by registered or certified mail on the
third day after registration or certification thereof.
9.3
Applicable Law
. The validity, interpretation, and performance of this
Warrant Agreement and of the Warrants shall be governed in all respects by the laws of the State of
New York, without giving effect to conflict of laws. The Company hereby agrees that any action,
proceeding or claim against it arising out of or relating in any way to this Warrant Agreement
shall be brought and enforced in the courts of the State of New York or the United States District
Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which
jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive
jurisdiction and that such courts represent an inconvenient forum. Any process or summons to be
served upon the Company may be served by transmitting a copy thereof by registered or certified
mail, return receipt requested, postage prepaid, addressed to it at the address set forth in
Section 9.2 hereof. Such mailing shall be deemed personal service and shall be legal and binding
upon the Company in any action, proceeding or claim.
9.4
Persons Having Rights under this Warrant Agreement
. Nothing in this
Warrant Agreement expressed and nothing that may be implied from any of the provisions hereof is
intended, or shall be construed, to confer upon, or give to, any person or corporation other than
the parties hereto and the Registered Holders of the Warrants and, for the purposes of Sections
7.4, 9.2 and 9.8 hereof, the underwriters in the public offering, any right, remedy, or claim under
or by reason of this Warrant Agreement or of any covenant, condition, stipulation, promise, or
agreement hereof. Each underwriter in the public offering shall be deemed to be a third-party
beneficiary of this Warrant Agreement with respect to Sections 7.4, 9.2 and 9.8 hereof. All
covenants, conditions, stipulations, promises, and agreements contained in this Warrant Agreement
shall be for the sole and exclusive benefit of the parties hereto (and the underwriters in the
public offering with respect to the Sections 7.4, 9.2 and 9.8 hereof) and their successors and
assigns and of the Registered Holders of the Warrants.
9.5
Examination of the Warrant Agreement
. A copy of this Warrant Agreement
shall be available at all reasonable times at the office of the Warrant Agent for inspection by the
Registered Holder of any Warrant. The Warrant Agent may require any such holder to submit his, her
or its Warrant for inspection.
- 12 -
9.6
Counterparts- Facsimile Signatures
. This Warrant Agreement may be
executed in any number of counterparts, and each of such counterparts shall, for all purposes, be
deemed to be an original, and all such counterparts shall together constitute one and the same
instrument. Facsimile signatures shall constitute original signatures for all purposes of this
Warrant Agreement.
9.7
Effect of Headings
. The section headings herein are for convenience only
and are not part of this Warrant Agreement and shall not affect the interpretation thereof.
9.8
Amendments
.
9.8.1 This Warrant Agreement and any Warrant certificate may be amended by the
parties hereto by executing a supplemental warrant agreement (a
Supplemental Agreement
), without
the consent of any of the Warrant holders, for the purpose of (i) curing any ambiguity, or curing,
correcting or supplementing any defective provision contained herein, or making any other
provisions with respect to matters or questions arising under this Warrant Agreement that is not
inconsistent with the provisions of this agreement or the Warrant certificates, (ii) evidencing the
succession of another corporation to the Company and the assumption by any such successor of the
covenants of the Company contained in this Warrant Agreement and the Warrants, (iii) evidencing and
providing for the acceptance of appointment by a successor Warrant Agent with respect to the
Warrants, (iv) adding to the covenants of the Company for the benefit of the Holders or
surrendering any right or power conferred upon the Company under this Agreement, or (viii) amending
this Warrant Agreement and the Warrants in any manner that the Company may deem to be necessary or
desirable and that will not adversely affect the interests of the Warrant holders in any material
respect.
9.8.2 The Company and the Warrant Agent may amend this Warrant Agreement and the
Warrants by executing a Supplemental Agreement with the consent of the Holders of not fewer than a
majority of the unexercised Warrants affected by such amendment, for the purpose of adding any
provisions to or changing in any manner or eliminating any of the provisions of this Warrant
Agreement or of modifying in any manner the rights of the Holders under this Warrant Agreement;
provided, however, that, without the consent of each of the Warrant holders affected thereby, no
such amendment may be made that (i) changes the Warrants so as to reduce the number of shares
purchasable upon exercise of the Warrants or so as to increase the Warrant Price (other than as
provided by Section 4), (ii) shortens the period of time during which the Warrants may be
exercised, (iii) otherwise adversely affects the exercise rights of the Holders in any material
respect, or (iv) reduces the number of unexercised Warrants the holders of which must consent for
amendment of this Warrant Agreement or the Warrants. Notwithstanding anything contained herein to
the contrary, Section 9 may be amended only by the parties hereto with the consent of Maxim Group
LLC. If requested by the Warrant Agent, the Company shall cause a legal opinion, covering such
matters as are customary in connection with such amendments, to be delivered to the Warrant Agent
upon execution of a Supplemental Agreement.
9.8.3 The parties hereto acknowledge that each underwriters in the public offering
shall be an intended third party beneficiary of this Section 9.8.
- 13 -
9.9
Severability
. This Warrant Agreement shall be deemed severable, and the
invalidity or unenforceability of any term or provision hereof shall not affect the validity or
enforceability of this Warrant Agreement or of any other term or provision hereof. Furthermore, in
lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there
shall be added as a part of this Warrant Agreement a provision as similar in terms to such invalid
or unenforceable provision as may be possible and be valid and enforceable.
IN WITNESS WHEREOF, this Warrant Agreement has been duly executed by the parties hereto as of
the day and year first above written.
|
|
|
|
|
|
REGENERX BIOPHARMACEUTICALS, INC.
|
|
|
By:
|
/s/
J.J. Finkelstein
|
|
|
|
Name:
|
J.J. Finkelstein
|
|
|
|
Title:
|
President and Chief Executive Officer
|
|
|
|
|
|
|
|
|
AMERICAN STOCK TRANSFER &
TRUST COMPANY, LLC
|
|
|
By:
|
/s/
Herbert J. Lemmer
|
|
|
|
Name:
|
Herbert J. Lemmer
|
|
|
|
Title:
|
Vice President
|
|
- 14 -
EXHIBIT A
Form of Warrant
|
|
|
|
|
WARRANT NO.
|
|
|
|
WARRANTS
|
|
|
|
|
|
|
|
THIS WARRANT WILL BE VOID IF NOT EXERCISED PRIOR
|
|
|
|
|
TO 5:00 P.M. NEW YORK CITY
TIME, May 21, 2015
|
|
|
REGENERX BIOPHARMACEUTICALS, INC.
CUSIP
75886X 116
WARRANT
THIS CERTIFIES THAT, for value received
is the
registered holder of a Warrant or Warrants expiring May 21, 2015 (the Warrant) to purchase
one fully paid and non-assessable share of Common Stock, par value $0.001 per share (Shares), of
RegeneRx Biopharmaceuticals, Inc.
, a Delaware corporation (the Company), for each Warrant
evidenced by this Warrant Certificate. The Warrant entitles the holder thereof to purchase from
the Company such number of Shares of the Company at the price of
$0.56 per share, upon surrender of
this Warrant Certificate and payment of the Warrant Price (as defined below) at the office or
agency of the Warrant Agent, American Stock Transfer & Trust Company, LLC (such payment to be made
by certified check made payable to the Company or by wire transfer of immediately available funds
to an account designated by the Company), subject to the conditions set forth herein and in the
Warrant Agreement between the Company and the warrant agent named therein (the Warrant
Agreement). Notwithstanding anything else in this Warrant Certificate, or the Warrant Agreement,
no Warrant may be exercised unless at the time of exercise (i) a registration statement covering
the Warrant Shares to be issued upon exercise is effective under the Act and (ii) a prospectus
thereunder relating to the Warrant Shares is current. In no event shall the registered holder of
this Warrant be entitled to receive a net-cash settlement, shares of common stock or other
consideration in lieu of physical settlement in Shares of the Company. The Warrant Agreement
provides that upon the occurrence of certain events the Warrant Price and the number of Shares
purchasable hereunder, set forth on the face hereof, may, subject to certain conditions, be
adjusted. The term Warrant Price as used in this Warrant Certificate refers to the price per
Share at which Shares may be purchased at the time the Warrant is exercised.
This Warrant will expire at the time and date first above written if it is not exercised prior
to such time and date by the registered holder pursuant to the terms of the Warrant Agreement or if
it is not redeemed by the Company prior to such time and date.
No fraction of a Share will be issued upon any exercise of a Warrant. If the holder of a
Warrant would be entitled to receive a fraction of a Share upon any exercise of a Warrant, the
Company shall, upon such exercise, round up to the nearest whole number the number of Shares to be
issued to such holder.
Upon any exercise of the Warrant for less than the total number of full Shares provided for
herein, there shall be issued to the registered holder hereof or his assignee a new Warrant
Certificate covering the number of Shares for which the Warrant has not been exercised.
Warrant Certificates, when surrendered at the office or agency of the Warrant Agent by the
registered holder hereof in person or by attorney duly authorized in writing, may be exchanged in
the manner and subject to the limitations provided in the Warrant Agreement, but without payment of
any service charge, for another Warrant Certificate or Warrant Certificates of like tenor and
evidencing in the aggregate a like number of Warrants.
Upon due presentment for registration of transfer of the Warrant Certificate at the office or
agency of the Warrant Agent, a new Warrant Certificate or Warrant Certificates of like tenor and
evidencing in the aggregate a like number of Warrants shall be issued to the transferee in exchange
for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without
charge except for any applicable tax or other governmental charge.
A-1
The Company and the Warrant Agent may deem and treat the registered holder as the absolute
owner of this Warrant Certificate (notwithstanding any notation of ownership or other writing
hereon made by anyone), for the
purpose of any exercise hereof, of any distribution to the registered holder, and for all
other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to
the contrary.
This Warrant does not entitle the registered holder to any of the rights of a stockholder of
the Company.
The Company reserves the right to call the Warrant prior to its exercise, with a notice of
call in writing to the holder of record of the Warrant, giving 30 days notice of such call at any
time while the Warrant is exercisable if the last sale price of the
Shares has been at least $1.78
per share on each of 20 trading days within a 30 trading day period ending on the third business
day prior to the date on which notice of such call is given. The call price of the Warrants is to
be $0.01 per Warrant. Any Warrant either not exercised or tendered back to the Company by the end
of the date specified in the notice of call shall be canceled on the books of the Company and have
no further value except for the $0.01 call price.
REGENERX BIOPHARMACEUTICALS, INC.
By:
|
|
|
President
|
|
Assistant Secretary and Treasurer
|
COUNTERSIGNED:
AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC
(New York, NY)
AS WARRANT AGENT
By:
A-2
SUBSCRIPTION FORM
To Be Executed by the Registered Holder in Order to Exercise Warrants
The undersigned Registered Holder irrevocably elects to exercise
Warrants
represented by this Warrant Certificate, and to purchase the shares of Common Stock issuable upon
the exercise of such Warrants, and requests that Certificates for such shares shall be issued in
the name of
(PLEASE TYPE OR PRINT NAME AND ADDRESS)
(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER)
and be delivered to
(PLEASE PRINT OR TYPE NAME AND ADDRESS)
and, if such number of Warrants shall not be all the Warrants evidenced by this Warrant
Certificate, that a new Warrant Certificate for the balance of such Warrants be registered in the
name of, and delivered to, the Registered Holder at the address stated below:
|
|
|
|
|
Dated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(SIGNATURE)
|
|
|
|
|
|
|
|
|
|
(ADDRESS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(TAX IDENTIFICATION NUMBER)
|
Signature Guaranteed:
THE SIGNATURE TO THE SUBSCRIPTION FORM MUST CORRESPOND TO THE NAME WRITTEN
UPON THE FACE OF THIS
WARRANT CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE
WHATSOEVER, AND MUST BE GUARANTEED BY A COMMERCIAL BANK OR TRUST COMPANY OR A MEMBER FIRM OF THE
AMERICAN STOCK EXCHANGE, NEW YORK STOCK EXCHANGE, PACIFIC STOCK EXCHANGE OR CHICAGO STOCK EXCHANGE.
ASSIGNMENT
To Be Executed by the Registered Holder in Order to Assign Warrants
For Value Received,
hereby sell, assign, and transfer unto
(PLEASE TYPE OR PRINT NAME AND ADDRESS)
A-3
(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER)
and be delivered to
(PLEASE PRINT OR TYPE NAME AND ADDRESS)
of the Warrants represented by this Warrant Certificate, and hereby
irrevocably constitute and appoint
Attorney to transfer this Warrant
Certificate on the books of the Company, with full power of substitution in the premises.
Signature Guaranteed:
THE SIGNATURE TO THE ASSIGNMENT OF THE SUBSCRIPTION FORM MUST CORRESPOND TO THE NAME WRITTEN UPON
THE FACE OF THIS WARRANT CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY
CHANGE WHATSOEVER, AND MUST BE GUARANTEED BY A COMMERCIAL BANK OR TRUST COMPANY OR A MEMBER FIRM OF
THE AMERICAN STOCK EXCHANGE, NEW YORK STOCK EXCHANGE, PACIFIC STOCK EXCHANGE OR CHICAGO STOCK
EXCHANGE.
A-4
Exhibit 4.3
THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT), OR ANY OTHER SECURITIES LAWS AND MAY
NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN
EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECURITIES ACT AND ANY OTHER
APPLICABLE SECURITIES LAWS, OR (2) AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY
THAT SUCH REGISTRATION IS NOT REQUIRED.
REGENERX BIOPHARMACEUTICALS, INC.
WARRANT
805,000 Common Shares
May 21, 2010
This
WARRANT
(this
Warrant
) of RegeneRx Biopharmaceuticals, Inc., a corporation duly
organized and validly existing under the laws of the State of Delaware (the
Company
), is being
issued pursuant to that certain Underwriting Agreement, dated as of
May 17, 2010, by and between
the Company and Maxim Group LLC, the representative of the underwriters (the
Representative
)
relating to a firm commitment public offering (the
Offering
) of an aggregate of 11,500,000 units,
each unit consisting of (i) one share of common stock, par value of $0.001 of the Company (each a
Common Share
and collectively, the
Common
Shares
) and (ii) 0.4 Warrants to purchase one Common
Share.
FOR VALUE RECEIVED
, the Company hereby grants to Maxim Group LLC and its permitted successors
and assigns (collectively, the
Holder
) the right
to purchase from the Company up to 805,000
(eight hundred five thousand) Common Shares (such Common Shares underlying this Warrant, the
Warrant Shares
), at
a per share purchase price equal to $0.45 (the
Exercise Price
), subject to the terms,
conditions, and adjustments set forth below in this Warrant.
1.
Vesting of Warrant
. This Warrant shall vest and become exercisable on the six (6)
month anniversary of the Base Date (the
Vesting Date
). For purposes of this Warrant, the
Base
Date
shall mean May 17, 2010. Except as otherwise provided for herein or as permitted by
applicable rules of the Financial Industry Regulatory Authority (
FINRA
), this Warrant shall not
be sold, transferred, assigned, pledged, or hypothecated prior to the Vesting Date.
2.
Expiration of Warrant
. This Warrant shall expire on the five (5) year anniversary
of the Base Date (the
Expiration Date
).
3.
Exercise of Warrant
. This Warrant shall be exercisable pursuant to the terms of
this Section 3.
3.1
Manner of Exercise
.
(a) This Warrant is exercisable in whole or in part at any time and from time to time. Such
exercise shall be effectuated by submitting to the Company (either by delivery to the Company or by
facsimile transmission as provided in Section 12 hereof) a completed and duly executed Notice of
Exercise (substantially in the form attached as
Exhibit A
hereto) as provided in this
paragraph. The date such Notice of Exercise is faxed or delivered to the Company shall be the
Exercise Date
, provided that the Holder of this Warrant tenders this Warrant Certificate to the
Company within five (5) Business Days thereafter. As used in this Warrant,
Business Day
shall
mean any day other than a Saturday, Sunday, or any day on which the major stock exchanges in New
York, New York are not open for business. The Notice of Exercise shall be executed by the Holder
of this Warrant and shall indicate the number of Warrant Shares then being purchased pursuant to
such exercise. Upon surrender of this Warrant Certificate, together with appropriate payment of the
Exercise Price for the Warrant Shares purchased, the Holder shall be entitled to receive a
certificate or certificates for the Common Shares so purchased. The Exercise Price may be paid in
a cashless or cash exercise or a combination thereof pursuant to Section 3.1(b) and Section
3.1(c) below.
(b) If the Notice of Exercise form elects a cashless exercise, the Holder shall thereby be
entitled to receive a number of Common Shares determined as follows:
X
= Y [(A B)/A]
where:
X = the number of Warrant Shares to be issued to the Holder.
Y = the number of Warrant Shares with respect to which this Warrant is being
exercised.
A = the Fair Market Value
B = the Exercise Price.
For purposes of this Section 3.1(b),
Fair Market Value
shall be the closing price of the
Common Shares as reported by the OTC Bulletin Board, or if listed on a national securities exchange
or quoted on an automated quotation service, such national securities exchange or automated
quotation service, on the date immediately prior to the Exercise Date. If the Common Shares are
not then listed on a national stock exchange or quoted on the OTC Bulletin Board or such other
quotation system or association, the Fair Market Value of one Common Share as of the date of
determination, shall be as determined in good faith by the Board of Directors of the Company and
the Holder. If the Common Shares are not then listed on a national securities exchange, the OTC
Bulletin Board or such other quotation system or association, the Board of Directors of the Company
shall respond promptly, in writing, to an inquiry by the Holder prior to the exercise hereunder as
to the fair market value of an Common
2
Share as determined by the Board of Directors of the Company. In the event that the Board of
Directors of the Company and the Holder are unable to agree upon the fair market value, the Company
and the Holder shall jointly select an appraiser who is experienced in such matters. The decision
of such appraiser shall be final and conclusive, and the cost of such appraiser shall be borne
equally by the Company and the Holder.
(c) If the Notice of Exercise form elects a cash exercise, the Exercise Price per Common
Share for the shares then being exercised shall be payable in cash or by certified or official bank
check.
3.2
When Exercise Effective
. Each exercise of this Warrant shall be deemed to have
been effected immediately prior to the close of business on the Business Day on which this Warrant
shall have been duly surrendered to the Company, and at such time the Holder in whose name any
certificate or certificates for Warrant Shares shall be issuable upon exercise as provided in
Section 3.3 hereof shall be deemed to have become the Holder or Holders of record thereof of the
number of Warrant Shares purchased upon exercise of this Warrant.
3.3
Delivery of Common Share Certificates and New Warrant
. As soon as reasonably
practicable after each exercise of this Warrant, in whole or in part, and in any event within five
(5) Business Days thereafter, the Company, at its expense (including the payment by it of any
applicable issue taxes), will cause to be issued in the name of and delivered to the Holder hereof
or, subject to Sections 9 and 10 hereof, as the Holder (upon payment by the Holder of any
applicable transfer taxes) may direct:
(a) a certificate or certificates (with appropriate restrictive legends, as applicable) for
the number of duly authorized, validly issued, fully paid, and nonassessable Common Shares to which
the Holder shall be entitled upon exercise; and
(b) in case exercise is in part only, a new Warrant document of like tenor, dated the date
hereof, for the remaining number of Warrant Shares issuable upon exercise of this Warrant after
giving effect to the partial exercise of this Warrant (including the delivery of any Warrant Shares
as payment of the Exercise Price for such partial exercise of this Warrant).
4.
Certain Adjustments
. For so long as this Warrant is outstanding:
4.1
Mergers or Consolidations
. If at any time after the date hereof there shall be a
capital reorganization (other than a combination or subdivision of the Common Shares otherwise
provided for herein) resulting in a reclassification to or change in the terms of securities
issuable upon exercise of this Warrant (a
Reorganization
), or a merger or consolidation of the
Company with another corporation, association, partnership, organization, business, individual,
government or political subdivision thereof or a governmental agency (a
Person
or the
Persons
)
(other than a merger with another Person in which the Company is a continuing corporation and which
does not result in any reclassification or change in the terms of securities issuable upon exercise
of this Warrant or a merger effected exclusively for the purpose of changing the domicile of the
Company) (a
Merger
), then, as a part of such Reorganization or Merger, lawful provision and
adjustment shall be made so that the Holder shall thereafter be entitled to receive, upon exercise
of this Warrant, the number of shares of stock or any other
3
equity or debt securities or property receivable upon such Reorganization or Merger by a
holder of the number of Common Shares which might have been purchased upon exercise of this Warrant
immediately prior to such Reorganization or Merger. In any such case, appropriate adjustment shall
be made in the application of the provisions of this Warrant with respect to the rights and
interests of the Holder after the Reorganization or Merger to the end that the provisions of this
Warrant (including adjustment of the Exercise Price then in effect and the number of Warrant
Shares) shall be applicable after that event, as near as reasonably may be, in relation to any
shares of stock, securities, property or other assets thereafter deliverable upon exercise of this
Warrant. The provisions of this Section 4.1 shall similarly apply to successive Reorganizations
and Mergers.
4.2
Splits and Subdivisions; Dividends
. In the event the Company should at any time
or from time to time effectuate a split or subdivision of the outstanding Common Shares or pay a
dividend in or make a distribution payable in additional Common Shares or other securities or
rights convertible into, or entitling the holder thereof to receive, directly or indirectly,
additional Common Shares (hereinafter referred to as the
Common Share Equivalents
) without
payment of any consideration by such holder for the additional Common Shares or Common Shares
Equivalents (including the additional Common Shares issuable upon conversion or exercise thereof),
then, as of the applicable record date (or the date of such distribution, split or subdivision if
no record date is fixed), the per share Exercise Price shall be appropriately decreased and the
number of Warrant Shares shall be appropriately increased in proportion to such increase (or
potential increase) of outstanding shares; provided, however, that no adjustment shall be made in
the event the split, subdivision, dividend or distribution is not effectuated. Notwithstanding the
foregoing or anything else to the contrary herein, in no event shall the per share Exercise Price
be reduced below the par value of one Common Share or of such other securities as may be issued
upon exercise of the Warrant.
Pursuant to the anti-dilution terms of this Section 4.2, provided that the public shareholders
are proportionally affected by such split or subdivision, dividend, distribution, or other similar
event, the Representative may receive a greater number of Warrant Shares or the per share Exercise
Price may be lower than originally contemplated by this Warrant. Additionally, the Representative
shall not have the right to accrue cash dividends prior to the exercise or conversion of the
Warrant.
4.3
Combination of Shares
. If the number of Common Shares outstanding at any time
after the date hereof is decreased by a combination of the outstanding Common Shares, the per share
Exercise Price shall be appropriately increased and the number of shares of Warrant Shares shall be
appropriately decreased in proportion to such decrease in outstanding shares.
4.4
Adjustments for Other Distributions
. In the event the Company shall declare a
distribution payable in securities of other Persons, evidences of indebtedness issued by the
Company or other Persons, assets (excluding cash dividends or distributions to the holders of
Common Stock paid out of current or retained earnings and declared by the Companys Board of
Directors) or options or rights not referred to in Sections 4.1, 4.2, or 4.3, then, in each such
case for the purpose of this Section 4.4, upon exercise of this Warrant, the Holder shall be
entitled to a proportionate share of any such distribution as though the Holder was the actual
record holder of
4
the number of Warrant Shares as of the record date fixed for the determination of the holders
of Common Shares of the Company entitled to receive such distribution.
5.
No Impairment
. The Company will not, by amendment of its certificate of
incorporation or by-laws or through any consolidation, Merger, Reorganization, transfer of assets,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the
observance or performance of any of the terms of this Warrant, but will at all times in good faith
assist in the carrying out of all of the terms and in the taking of all actions necessary or
appropriate to protect the rights of the Holder against impairment.
6.
Chief Financial Officers Report as to Adjustments
. With respect to each
adjustment pursuant to Section 4 of this Warrant, the Company, at its expense, will promptly
compute the adjustment or re-adjustment in accordance with the terms of this Warrant and cause its
Chief Financial Officer to certify the computation (other than any computation of the fair value of
property of the Company) and prepare a report setting forth, in reasonable detail, the event
requiring the adjustment or re-adjustment and the amount of such adjustment or re-adjustment, the
method of calculation thereof and the facts upon which the adjustment or re-adjustment is based,
and the Exercise Price and the number of Warrant Shares or other securities purchasable hereunder
after giving effect to such adjustment or re-adjustment, which report shall be mailed by first
class mail, postage prepaid to the Holder. The Company will also keep copies of all reports at its
office maintained pursuant to Section 10.2(a) hereof and will cause them to be available for
inspection at the office during normal business hours upon reasonable notice by the Holder or any
prospective purchaser of the Warrant designated by the Holder thereof.
7.
Reservation of Shares
. The Company shall, solely for the purpose of effecting the
exercise of this Warrant, at all times during the term of this Warrant, reserve and keep available
out of its authorized Common Shares, free from all taxes, liens, and charges with respect to the
issue thereof and not subject to preemptive rights or other similar rights of shareholders of the
Company, such number of its Common Shares as shall from time to time be sufficient to effect in
full the exercise of this Warrant. If at any time the number of authorized but unissued Common
Shares shall not be sufficient to effect in full the exercise of this Warrant, in addition to such
other remedies as shall be available to Holder, the Company will promptly take such corporate
action as may, in the opinion of its counsel, be necessary to increase the number of authorized but
unissued Common Shares to such number of shares as shall be sufficient for such purposes, including
without limitation, using its best efforts to obtain the requisite shareholder approval necessary
to increase the number of authorized Common Shares. The Company hereby represents and warrants
that all Common Shares issuable upon exercise of this Warrant shall be duly authorized and, when
issued and paid for upon exercise, shall be validly issued, fully paid and nonassessable.
8.
Registration and Listing
.
8.1
Definition of Registrable Securities; Majority
. As used herein, the term
Registrable Securities
means any Common Shares issuable upon the exercise of this Warrant, until
the date (if any) on which such shares shall have been transferred or exchanged and new
certificates for them not bearing a legend restricting further transfer shall have been delivered
by
5
the Company and subsequent disposition of them shall not require registration or qualification
of them under the Securities Act or any similar state law then in force. For purposes of this
Warrant, the term
Majority
, in reference to the holders of Registrable Securities, shall mean in
excess of fifty percent (50%) of the then outstanding Registrable Securities (assuming the exercise
of the entire Warrant) that (i) are not held by the Company, an affiliate, officer, creditor,
employee or agent thereof or any of their respective affiliates, members of their family, Persons
acting as nominees or in conjunction therewith and (ii) have not be resold to the public pursuant
to a registration statement filed under the Securities Act.
8.2
Required Registration
.
(a) At any time on or after the six (6) month anniversary of the Base Date and on or before
the five (5) year anniversary of the Base Date, but in no event on more than two (2) occasions (the
Registration Expenses associated with second required registration effected (as described in
Section 8.2(c)) pursuant to this Section 8.2(a) shall be payable by the Holder pursuant to Section
8.6), upon the written request of the holders of the Registrable Securities representing a Majority
of such securities, the Company will use its best efforts to effect the registration of the
respective shares of the holders of Registrable Securities under the Securities Act to the extent
requisite to permit the disposition thereof as expeditiously as reasonably possible, but in no
event later than one hundred-twenty (120) days from the date of such request.
(b) Registration of Registrable Securities under this Section 8.2 shall be on such appropriate
registration form: (i) as shall be selected by the Company, and (ii) as shall permit the
disposition of such Registrable Securities in accordance with this Section 8.2. The Company agrees
to include in any such registration statement all information which the requesting holders of
Registrable Securities shall reasonably request, which is required to be contained therein. The
Company will pay all Registration Expenses in connection with the first, and only the first,
required registration of Registrable Securities effected (as described in Section 8.2(c)) pursuant
to this Section 8.2.
(c) A registration requested pursuant to this Section 8.2 shall not be deemed to have been
effected: (i) unless a registration statement with respect thereto has become effective or (ii) if,
after it has become effective, such registration is interfered with by any stop order, injunction
or other order or requirement of the Securities and Exchange Commission (the
SEC
) or other
governmental agency or court of competent jurisdiction for any reason, other than by reason of some
act or omission by a holder of Registrable Securities.
8.3
Incidental Registration Rights
.
(a) If the Company, at any time on or after the six (6) month anniversary of the Base Date and
on or before the five (5) year anniversary of the Base Date, proposes to register any of its
securities under the Securities Act (other than in connection with a registration on Form S-4 or
S-8 or any successor forms) whether for its own account or for the account of any holder or holders
of its shares other than Registrable Securities (any shares of such holder or holders (but not
those of the Company and not Registrable Securities) with respect to any registration are referred
to herein as,
Other Shares
), each such time the Company shall give
6
prompt (but not less than thirty (30) days prior to the anticipated effectiveness thereof)
written notice to the holders of Registrable Securities of its intention to do so. Upon the
written request of any such holder of Registrable Securities made within twenty (20) days after the
receipt of any such notice (which request shall specify the Registrable Securities intended to be
disposed of by such holder), except as set forth in Section 8.3(b), the Company will use its best
efforts to effect the registration under the Securities Act of all of the Registrable Securities
which the Company has been so requested to register by such holder, to the extent requisite to
permit the disposition of the Registrable Securities so to be registered, by inclusion of such
Registrable Securities in the registration statement which covers the securities which the Company
proposes to register;
provided
,
however
,
that if, at any time after giving written
notice of its intention to register any securities and prior to the effective date of the
registration statement filed in connection with such registration, the Company shall determine for
any reason in its sole discretion either to not register, to delay or to withdraw registration of
such securities, the Company may, at its election, give written notice of such determination to
such holder and, thereupon, (i) in the case of a determination not to register, shall be relieved
of its obligation to register any Registrable Securities in connection with such registration (but
not from its obligation to pay the Registration Expenses in connection therewith), without
prejudice, however, to the rights of the holders of Registrable Securities entitled to request that
such registration be effected as a registration under Section 8.2, (ii) in the case of a
determination to delay registration, shall be permitted to delay registering any Registrable
Securities for the same period as the delay in registering such other securities (including the
Other Shares), without prejudice, however, to the rights of the holders of Registrable Securities
entitled to request that such registration be effected as a registration under Section 8.2 and
(iii) in the case of a determination to withdraw registration, shall be permitted to withdraw
registration, without prejudice, however, to the rights of the holders of Registrable Securities
entitled to request that such registration be effected as a registration under Section 8.2. No
registration effected under this Section 8.3 shall relieve the Company of its obligation to effect
any registration upon request under Section 8.2, nor shall any such registration hereunder be
deemed to have been effected pursuant to Section 8.2. The Company will pay all Registration
Expenses in connection with each registration of Registrable Securities pursuant to this Section
8.3.
(b) If the Company at any time proposes to register any of its securities under the Securities
Act as contemplated by this Section 8.3 and such securities are to be distributed by or through one
or more underwriters, the Company will, if requested by a holder of Registrable Securities, use its
best efforts to arrange for such underwriters to include all the Registrable Securities to be
offered and sold by such holder among the securities to be distributed by such underwriters,
provided that if the managing underwriter of such underwritten offering shall inform the Company by
letter of its belief that inclusion in such distribution of all or a specified number of such
securities proposed to be distributed by such holders of Registrable Securities or Other Shares
would interfere with the successful marketing of the securities being distributed by the Company
(such letter to state the basis of such belief and the approximate number of such Registrable
Securities, such Other Shares and shares held by the Company proposed so to be registered which may
be distributed without such effect) (the
Underwriters Letter
), then the Company may, upon
written notice to such holder, the other holders of Registrable Securities, and holders of such
Other Shares, reduce pro rata in accordance with the number of Common Shares desired to be included
in such registration (if and to the extent stated by such managing
7
underwriter to be necessary to eliminate such effect) the number of such Registrable
Securities and Other Shares the registration of which shall have been requested by each holder
thereof so that the resulting aggregate number of such Registrable Securities and Other Shares so
included in such registration, together with the number of securities to be included in such
registration for the account of the Company, shall be equal to the number of shares stated in the
Underwriters Letter.
8.4
Registration Procedures
. Whenever the holders of Registrable Securities have
properly requested that any Registrable Securities be registered pursuant to the terms of this
Warrant, the Company shall use its best efforts to effect the registration and the sale of such
Registrable Securities in accordance with the intended method of disposition thereof, and pursuant
thereto the Company shall as expeditiously as possible:
(a) prepare and file with the SEC a registration statement with respect to such Registrable
Securities and use its best efforts to cause such registration statement to become effective;
(b) notify such holders of the effectiveness of each registration statement filed hereunder
and prepare and file with the SEC such amendments and supplements to such registration statement
and the prospectus used in connection therewith as may be necessary to (i) keep such registration
statement effective and the prospectus included therein usable for a period commencing on the date
that such registration statement is initially declared effective by the SEC and ending on the date
when all Registrable Securities covered by such registration statement have been sold pursuant to
the registration statement or cease to be Registrable Securities, and (ii) comply with the
provisions of the Securities Act with respect to the disposition of all securities covered by such
registration statement during such period in accordance with the intended methods of disposition by
the sellers thereof set forth in such registration statement;
(c) furnish to such holders such number of copies of such registration statement, each
amendment and supplement thereto, the prospectus included in such registration statement (including
each preliminary prospectus) and such other documents as such seller may reasonably request to
facilitate the disposition of the Registrable Securities owned by such holders;
(d) use its best efforts to register or qualify such Registrable Securities under such other
securities or blue sky laws of such jurisdictions as such holders reasonably request and do any and
all other acts and things which may be reasonably necessary or advisable to enable such holders to
consummate the disposition in such jurisdictions of the Registrable Securities owned by such
holders;
provided
,
however
, that the Company shall not be required to: (i) qualify
generally to do business in any jurisdiction where it would not otherwise be required to qualify
but for this subparagraph, (ii) subject itself to taxation in any such jurisdiction, or (iii)
consent to general service of process in any such jurisdiction;
(e) notify such holders, at any time when a prospectus relating thereto is required to be
delivered under the Securities Act, of the happening of any event as a result of which the
prospectus included in such registration statement contains an untrue statement of a material fact
or omits any material fact necessary to make the statements therein, in light of the
8
circumstances in which they are made, not materially misleading, and, at the reasonable
request of such holders, the Company shall prepare a supplement or amendment to such prospectus so
that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus
shall not contain an untrue statement of a material fact or omit to state any material fact
necessary to make the statements therein, in light of the circumstances in which they are made, not
materially misleading;
(f) provide a transfer agent and registrar for all such Registrable Securities not later than
the effective date of such registration statement;
(g) make available for inspection by any underwriter participating in any disposition pursuant
to such registration statement, and any attorney, accountant or other agent retained by any such
underwriter, all financial and other records, pertinent corporate documents and properties of the
Company, and cause the Companys officers, directors, managers, employees and independent
accountants to supply all information reasonably requested by any such underwriter, attorney,
accountant or agent in connection with such registration statement;
(h) otherwise use its best efforts to comply with all applicable rules and regulations of the
SEC, and make available to its security holders, as soon as reasonably practicable, an earnings
statement of the Company, which earnings statement shall satisfy the provisions of Section 11(a) of
the Securities Act and, at the option of the Company, Rule 158 thereunder;
(i) in the event of the issuance of any stop order suspending the effectiveness of a
registration statement, or of any order suspending or preventing the use of any related prospectus
or suspending the qualification of any Registrable Securities included in such registration
statement for sale in any jurisdiction, the Company shall use its best efforts promptly to obtain
the withdrawal of such order;
(j) use its best efforts to cause any Registrable Securities covered by such registration
statement to be registered with or approved by such other governmental agencies or authorities as
may be necessary to enable the sellers thereof to consummate the disposition of such Registrable
Securities; and
(k) if the offering is underwritten, use its best efforts to furnish on the date that
Registrable Securities are delivered to the underwriters for sale pursuant to such registration, an
opinion dated such date of counsel representing the Company for the purposes of such registration,
addressed to the underwriters covering such issues as are customarily addressed in opinions to
underwriters in public offerings and reasonably required by such underwriters.
8.5
[Intentionally Omitted]
.
8.6
Expenses
. The Company shall pay all Registration Expenses relating to the
registration and listing obligations set forth in this Section 8, except that the Holder shall be
responsible for the Registration Expenses for the second required registration effected pursuant to
Section 8.2(a). For purposes of this Warrant, the term
Registration Expenses
means: (a) all
9
registration, filing and FINRA fees, (b) all reasonable fees and expenses of complying with
securities or blue sky laws, (c) all word processing, duplicating and printing expenses, (d) the
fees and disbursements of counsel for the Company and of its independent public accountants,
including the expenses of any special audits or cold comfort letters required by or incident to
such performance and compliance, (e) premiums and other costs of policies of insurance (if any)
against liabilities arising out of the public offering of the Registrable Securities being
registered if the Company desires such insurance, if any, and (f) fees and disbursements of one
counsel for all of the selling holders of Registrable Securities. Registration Expenses shall not
include any underwriting discounts and commissions which may be incurred in the sale of any
Registrable Securities and transfer taxes of the selling holders of Registrable Securities.
8.7
Restrictions
. The Company shall not be obligated to effect a registration
pursuant to Section 8.2 during the period beginning on the date sixty (60) days prior to the
Companys good faith estimate of the date of filing of, and ending on a date one hundred twenty
(120) days after the effective date of, a Company-initiated registration (other than a registration
pursuant to Form S-8), provided that: (i) if the holder of Registrable Securities elects to have
all or some of its Registrable Securities included in the registration pursuant to Section 8.3
hereof, such Registrable Securities are included in the Company-initiated registration statement to
the extent required hereunder and (ii) the Company is actively employing its best efforts to cause
such registration to become effective.
8.8
Information Provided by Holders
. Any holder of Registrable Securities included in
any registration shall furnish to the Company such information as the Company may reasonably
request in writing to enable the Company to comply with the provisions hereof in connection with
any registration referred to in this Warrant. In the event that a holder of Registrable Securities
fails to provide such information on a timely basis, and in any event within seven (7) Business
Days of the Companys written request, then the Company shall be entitled to exclude the
Registrable Securities of such holder from such registration and the Company shall nevertheless be
deemed to have satisfied its obligations hereunder with respect to such registration.
9.
Restrictions on Transfer
.
9.1
Restrictive Legends
. This Warrant and each Warrant issued upon transfer or in
substitution for this Warrant pursuant to Section 10 hereof, each certificate for Common Shares
issued upon the exercise of the Warrant and each certificate issued upon the transfer of any such
Common Shares shall be transferable only upon satisfaction of the conditions specified in this
Section 9. Each of the foregoing securities shall be stamped or otherwise imprinted with a legend
reflecting the restrictions on transfer set forth herein and any restrictions required under the
Securities Act or other applicable securities laws.
9.2
Notice of Proposed Transfer
. Prior to any transfer of any securities which are
not registered under an effective registration statement under the Securities Act (
Restricted
Securities
), which transfer may only occur if there is an exemption from the registration
provisions of the Securities Act and all other applicable securities laws, the Holder will give
written notice to the Company of the Holders intention to effect a transfer (and shall describe
10
the manner and circumstances of the proposed transfer). The following provisions shall apply
to any proposed transfer of Restricted Securities:
(i) If in the opinion of counsel for the Holder reasonably satisfactory to the Company the
proposed transfer may be effected without registration of the Restricted Securities under the
Securities Act (which opinion shall state in detail the basis of the legal conclusions reached
therein), the Holder shall, upon delivery of an executed original of such opinion, be entitled to
transfer the Restricted Securities in accordance with the terms of the notice delivered by the
Holder to the Company. Each certificate representing the Restricted Securities issued upon or in
connection with any transfer shall bear the restrictive legends required by Section 9.1 hereof.
(ii) If the opinion called for in (i) above is not delivered, the Holder shall not be entitled
to transfer the Restricted Securities until either (x) receipt by the Company of a further notice
from such Holder pursuant to the foregoing provisions of this Section 9.2 and fulfillment of the
provisions of clause (i) above, or (y) such Restricted Securities have been effectively registered
under the Securities Act.
9.3
Certain Other Transfer Restrictions
. Notwithstanding any other provision of this
Section 9: (i) prior to the Vesting Date, this Warrant or the Restricted Securities thereunder may
only be transferred or assigned to the persons permitted under FINRA Rule 5110(g)(1), and (ii) no
opinion of counsel shall be necessary for a transfer of Restricted Securities by the Holder to any
Person employed by or owning equity in the Holder, if the transferee agrees in writing to be
subject to the terms hereof to the same extent as if the transferee were the original holder hereof
and such transfer is permitted under applicable securities laws.
9.4
Termination of Restrictions
. The restrictions imposed by this Section 9 upon the
transferability of Restricted Securities shall cease and terminate as to any particular Restricted
Securities: (a) which shall have been effectively registered under the Securities Act, or (b) when,
in the opinions of both counsel for the Holder and counsel for the Company, such restrictions are
no longer required to insure compliance with the Securities Act. Whenever such restrictions shall
cease and terminate as to any Restricted Securities, the Holder shall be entitled to receive from
the Company, without expense (other than applicable transfer taxes, if any), new securities of like
tenor not bearing the applicable legends required by Section 9.1 hereof.
10.
Ownership, Transfer and Substitution of Warrant
.
10.1
Ownership of Warrant
. The Company may treat any Person in whose name this
Warrant is registered in the Warrant Register maintained pursuant to Section 10.2(b) hereof as the
owner and Holder for all purposes, notwithstanding any notice to the contrary, except that, if and
when any Warrant is properly assigned in blank, the Company may (but shall not be obligated to)
treat the bearer thereof as the owner of such Warrant for all purposes, notwithstanding any notice
to the contrary. Subject to Sections 9 and 10 hereof, this Warrant, if properly assigned, may be
exercised by a new Holder without a new Warrant first having been issued.
11
10.2
Office; Exchange of Warrant
.
(a) The Company will maintain its principal office at the location identified in the
prospectus relating to the Offering or at such other offices as set forth in the Companys most
current filing under the Securities Exchange Act of 1934, as amended, or as the Company otherwise
notifies the Holder.
(b) The Company shall cause to be kept at its office a Warrant Register for the registration
and transfer of the Warrant. The name and address of the Holder of the Warrant, the transfers
thereof and the name and address of the transferee of the Warrant shall be registered in such
Warrant Register.
(c) Upon the surrender of this Warrant, properly endorsed, for registration of transfer or for
exchange at the office of the Company maintained pursuant to Section 10.2(a) hereof, the Company at
its expense will (subject to compliance by the Holder with Section 9 hereof, if applicable) execute
and deliver to or upon the order of the Holder thereof a new Warrant of like tenor, in the name of
such Holder or as such Holder (upon payment by such holder of any applicable transfer taxes) may
direct, calling in the aggregate on the face thereof for the number of Common Shares called for on
the face of the Warrant so surrendered (after giving effect to any previous adjustment(s) to the
number of Warrant Shares).
10.3
Replacement of Warrant
. Upon receipt of evidence reasonably satisfactory to the
Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of any such
loss, theft or destruction of this Warrant, upon delivery of indemnity reasonably satisfactory to
the Company in form and amount or, in the case of any mutilation, upon surrender of this Warrant
for cancellation at the office of the Company maintained pursuant to Section 10.2(a) hereof, the
Company, at its expense, will execute and deliver, in lieu thereof, a new Warrant of like tenor and
dated the date hereof.
11.
No Rights or Liabilities as Stockholder
. Except as provided in Section 4.4, no
Holder shall be entitled to vote or receive dividends or be deemed the holder of any Common Shares
or any other securities of the Company which may at any time be issuable on the exercise hereof for
any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such,
any of the rights of a stockholder of the Company or any right to vote for the election of
directors or upon any matter submitted to stockholders at any meeting thereof, or to give or
withhold consent to any corporate action (whether upon any recapitalization, issuance of stock,
reclassification of stock, change of par value, consolidation, Merger, conveyance, or otherwise) or
to receive notice of meetings, or to receive dividends or subscription rights or otherwise until
the Warrant shall have been exercised and the Common Shares purchasable upon the exercise hereof
shall have become deliverable, as provided herein. The Holder will not be entitled to share in the
assets of the Company in the event of a liquidation, dissolution or the winding up of the Company.
12.
Notices
. Any notice or other communication in connection with this Warrant shall
be given in writing and directed to the parties hereto as follows: (a) if to the Holder, c/o
12
Maxim Group LLC, 405 Lexington Avenue, New York, NY 10174, Attn: David Strupp, Fax No: (212)
895-3783 or (b) if to the Company, to the attention of its Chief Executive Officer at its office
maintained pursuant to Section 10.2(a) hereof;
provided
,
that the exercise of the Warrant
shall also be effected in the manner provided in Section 3 hereof. Notices shall be deemed
properly delivered and received when delivered to the notice party (i) if personally delivered,
upon receipt or refusal to accept delivery, (ii) if sent via facsimile, upon mechanical
confirmation of successful transmission thereof generated by the sending telecopy machine, (iii) if
sent by a commercial overnight courier for delivery on the next Business Day, on the first Business
Day after deposit with such courier service, or (iv) if sent by registered or certified mail, five
(5) Business Days after deposit thereof in the U.S. mail.
13.
Payment of Taxes
. The Company will pay all documentary stamp taxes attributable
to the issuance of Common Shares underlying this Warrant upon exercise of this Warrant;
provided
,
however
, that the Company shall not be required to pay any tax which may
be payable in respect of any transfer involved in the transfer or registration of this Warrant or
any certificate for Common Shares underlying this Warrant in a name other that of the Holder. The
Holder is responsible for all other tax liability that may arise as a result of holding or
transferring this Warrant or receiving Common Shares underlying this Warrant upon exercise hereof.
14.
Miscellaneous
. This Warrant and any term hereof may be changed, waived,
discharged or terminated only by an instrument in writing signed by the party against which
enforcement of the change, waiver, discharge or termination is sought. This Warrant shall be
construed and enforced in accordance with and governed by the laws of the State of New York. The
section headings in this Warrant are for purposes of convenience only and shall not constitute a
part hereof.
[Signature Page Follows]
13
IN WITNESS WHEREOF
, the Company has caused this Warrant to be duly executed as of the date
first above written.
|
|
|
|
|
|
REGENERX BIOPHARMACEUTICALS, INC.
|
|
|
By:
|
/s/
J.J. Finkelstein
|
|
|
|
Name:
|
J.J. Finkelstein
|
|
|
|
Title:
|
President and Chief Executive Officer
|
|
|
[Signature Page to Representatives Warrant]
14
EXHIBIT A
FORM OF EXERCISE NOTICE
[To be executed only upon exercise of Warrant]
To RegeneRx Biopharmaceuticals, Inc.:
The undersigned registered holder of the within Warrant hereby irrevocably exercises the
Warrant pursuant to Section 3.1 of the Warrant with respect to
Warrant Shares, at an
exercise price per share of $___, and requests that the certificates for such Warrant Shares be
issued, subject to Sections 9 and 10, in the name of, and delivered to:
The undersigned is hereby making payment for the Warrant Shares in the following manner:
[describe desired payment method as provided for in 3.1 of the Warrant].
The undersigned hereby represents and warrants that it is, and has been since its acquisition
of the Warrant, the record and beneficial owner of the Warrant.
Dated:
|
|
|
|
|
|
|
|
|
|
|
|
Print or Type Name
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Signature must conform in all respects to name of holder as specified on the face of Warrant)
|
|
|
|
|
|
|
|
|
|
|
|
|
(Street Address)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(City) (State) (Zip Code)
|
|
|
EXHIBIT B
FORM OF ASSIGNMENT
[To be executed only upon transfer of Warrant]
For value
received, the undersigned registered holder of the within Warrant hereby sells,
assigns, and transfers unto
[include name and addresses] the rights
represented by the Warrant to purchase
Common Shares of RegeneRx Biopharmaceuticals,
Inc. to which the Warrant relates, and appoints
Attorney to make such
transfer on the books of RegeneRx Biopharmaceuticals, Inc. maintained for the purpose, with full
power of substitution in the premises.
|
|
|
Dated:
|
|
|
|
|
(Signature must conform in all respects
|
|
|
to name of holder as specified on the
|
|
|
face of Warrant)
|
|
|
|
|
|
(Street Address)
|
|
|
|
|
|
(City) (State) (Zip Code)
|
|
|
|
Signed in the presence of:
|
|
|
|
|
|
|
|
(Signature of Transferee)
|
|
|
|
|
|
(Street Address)
|
|
|
|
|
|
(City) (State) (Zip Code)
|
Signed in the presence of:
|
|
|